{
    "paper_id": "6781845d9c6d05c033a2a29380fa0a28952ba7e2",
    "metadata": {
        "title": "Placental transfer and safety in pregnancy of medications under investigation to treat COVID-19",
        "authors": [
            {
                "first": "Margaux",
                "middle": [],
                "last": "Louchet",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "H\u00f4pital Louis Mourier",
                    "location": {
                        "settlement": "Colombes",
                        "country": "France"
                    }
                },
                "email": ""
            },
            {
                "first": "Jeanne",
                "middle": [],
                "last": "Sibiude",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "H\u00f4pital Louis Mourier",
                    "location": {
                        "settlement": "Colombes",
                        "country": "France"
                    }
                },
                "email": ""
            },
            {
                "first": "Gilles",
                "middle": [],
                "last": "Peytavin",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "FHU PREMA",
                    "location": {
                        "settlement": "Paris",
                        "country": "France"
                    }
                },
                "email": ""
            },
            {
                "first": "Olivier",
                "middle": [],
                "last": "Picone",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "H\u00f4pital Louis Mourier",
                    "location": {
                        "settlement": "Colombes",
                        "country": "France"
                    }
                },
                "email": ""
            },
            {
                "first": "Jean-Marc",
                "middle": [],
                "last": "Tr\u00e9luyer",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Laurent",
                "middle": [],
                "last": "Mandelbrot",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "H\u00f4pital Louis Mourier",
                    "location": {
                        "settlement": "Colombes",
                        "country": "France"
                    }
                },
                "email": "laurent.mandelbrot@aphp.fr"
            },
            {
                "first": "Jean-Marc",
                "middle": [],
                "last": "Tr\u00e9-Luyer",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Universit\u00e9 de Paris",
                    "location": {
                        "settlement": "Paris",
                        "country": "France"
                    }
                },
                "email": ""
            }
        ]
    },
    "abstract": [],
    "body_text": [
        {
            "text": "The current COVID-19 pandemic is a global health emergency which affects all populations, 54 including pregnant women (1, 2) . COVID-19 disease can result in maternal morbidity and 55 against SARS-CoV-2, blocking infection (45) and virus replication with a IC50 of 9.12 (22) . 142",
            "cite_spans": [
                {
                    "start": 118,
                    "end": 121,
                    "text": "(1,",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 122,
                    "end": 124,
                    "text": "2)",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 270,
                    "end": 274,
                    "text": "(22)",
                    "ref_id": "BIBREF23"
                }
            ],
            "ref_spans": [],
            "section": "INTRODUCTION 52 53"
        },
        {
            "text": "Chloroquine is under investigation in several clinical studies for the treatment of COVID- 19 143 (46) . including miscarriages, no increased risk has been reported, including (57) . In humans, stud-155 ies have not shown any teratogenic or fetotoxic effect in the event following in utero expo-156 sure ; in particular no risk of ocular damage in newborns in a meta-analysis including 588 157 infants (58) . 158",
            "cite_spans": [
                {
                    "start": 91,
                    "end": 102,
                    "text": "19 143 (46)",
                    "ref_id": null
                },
                {
                    "start": 176,
                    "end": 180,
                    "text": "(57)",
                    "ref_id": "BIBREF30"
                },
                {
                    "start": 402,
                    "end": 406,
                    "text": "(58)",
                    "ref_id": "BIBREF31"
                }
            ],
            "ref_spans": [],
            "section": "INTRODUCTION 52 53"
        },
        {
            "text": "Hydroxychloroquine is also an anti-malarial derived from amino-4-quinoline with an anti-159 inflammatory action. It has a molecular mass of 335.9g/mol, is lipophilic and has 45% protein 160",
            "cite_spans": [],
            "ref_spans": [],
            "section": "INTRODUCTION 52 53"
        },
        {
            "text": "binding. It has demonstrated antiviral activity against SARS-CoV-2 in small in vitro studies 161 (59, 60) and some studies have reported that hydroxychloroquine reduces viral excretion 162 (29, 61) . \"Compassionate use has been authorized in COVID-19 patients (66) , and a large 163 number of observational studies have been performed worldwide been published with con-164 flicting conclusions on its efficacy and safety on COVID-19 (62) (63) (64) (65) (66) (67) (68) (69) (70) (71) , and randomized clinical 165 trials are currently underway (53 studies are available in clincaltrial.gov website with \"includ-166",
            "cite_spans": [
                {
                    "start": 97,
                    "end": 101,
                    "text": "(59,",
                    "ref_id": "BIBREF32"
                },
                {
                    "start": 102,
                    "end": 105,
                    "text": "60)",
                    "ref_id": "BIBREF33"
                },
                {
                    "start": 194,
                    "end": 197,
                    "text": "61)",
                    "ref_id": "BIBREF34"
                },
                {
                    "start": 260,
                    "end": 264,
                    "text": "(66)",
                    "ref_id": "BIBREF39"
                },
                {
                    "start": 433,
                    "end": 437,
                    "text": "(62)",
                    "ref_id": null
                },
                {
                    "start": 438,
                    "end": 442,
                    "text": "(63)",
                    "ref_id": "BIBREF36"
                },
                {
                    "start": 443,
                    "end": 447,
                    "text": "(64)",
                    "ref_id": "BIBREF37"
                },
                {
                    "start": 448,
                    "end": 452,
                    "text": "(65)",
                    "ref_id": "BIBREF38"
                },
                {
                    "start": 453,
                    "end": 457,
                    "text": "(66)",
                    "ref_id": "BIBREF39"
                },
                {
                    "start": 458,
                    "end": 462,
                    "text": "(67)",
                    "ref_id": "BIBREF40"
                },
                {
                    "start": 463,
                    "end": 467,
                    "text": "(68)",
                    "ref_id": "BIBREF42"
                },
                {
                    "start": 468,
                    "end": 472,
                    "text": "(69)",
                    "ref_id": "BIBREF43"
                },
                {
                    "start": 473,
                    "end": 477,
                    "text": "(70)",
                    "ref_id": "BIBREF44"
                },
                {
                    "start": 478,
                    "end": 482,
                    "text": "(71)",
                    "ref_id": "BIBREF45"
                }
            ],
            "ref_spans": [],
            "section": "INTRODUCTION 52 53"
        },
        {
            "text": "ing\" and randomized statement criteria.\" (NCT04329923, NCT 04307693, 167",
            "cite_spans": [],
            "ref_spans": [],
            "section": "INTRODUCTION 52 53"
        },
        {
            "text": "ChiCTR2000029559, ChiCTR2000029898-99, ChiCTR2000029992). 168",
            "cite_spans": [],
            "ref_spans": [],
            "section": "INTRODUCTION 52 53"
        },
        {
            "text": "Hydroxychloroquine is recommended for patients with rheumatoid arthritis and lupus. It 169 obtained marketing authorization in these indications in 1997 (72) . Hydroxychloroquine tox -170 icities are retinopathy in case of long-term treatment at high doses (prevalence from 2 to 171 8%) (73, 74) and heart conduction disorders (75) , more rarely ventricular tachyarrhythmia or 172 QT prolongation . 173 Hydroxychloroquine has been shown to be safe for use in pregnant women at doses of 200 174 mg once or twice a day. It crosses the placenta by passive diffusion with a strong correlation 175 between maternal and fetal concentrations and a fetal/maternal concentrations ratio of 176",
            "cite_spans": [
                {
                    "start": 84,
                    "end": 90,
                    "text": "It 169",
                    "ref_id": "BIBREF145"
                },
                {
                    "start": 153,
                    "end": 157,
                    "text": "(72)",
                    "ref_id": "BIBREF46"
                },
                {
                    "start": 183,
                    "end": 187,
                    "text": "-170",
                    "ref_id": null
                },
                {
                    "start": 287,
                    "end": 291,
                    "text": "(73,",
                    "ref_id": "BIBREF47"
                },
                {
                    "start": 292,
                    "end": 295,
                    "text": "74)",
                    "ref_id": "BIBREF48"
                },
                {
                    "start": 327,
                    "end": 331,
                    "text": "(75)",
                    "ref_id": "BIBREF49"
                },
                {
                    "start": 397,
                    "end": 402,
                    "text": ". 173",
                    "ref_id": null
                },
                {
                    "start": 486,
                    "end": 493,
                    "text": "200 174",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "INTRODUCTION 52 53"
        },
        {
            "text": "1.04 (range 0.51 to 1.82 ) (76) . Pregnancy outcomes in the event of exposure are similar to 177 those of untreated women with the same conditions (number of miscarriages and rate of 178 malformation in particular) (77) (78) (79) . There has been no reported increase in visual disturb -179 ances in newborns of exposed women (80) . 180 181",
            "cite_spans": [
                {
                    "start": 27,
                    "end": 31,
                    "text": "(76)",
                    "ref_id": "BIBREF50"
                },
                {
                    "start": 215,
                    "end": 219,
                    "text": "(77)",
                    "ref_id": "BIBREF51"
                },
                {
                    "start": 220,
                    "end": 224,
                    "text": "(78)",
                    "ref_id": "BIBREF52"
                },
                {
                    "start": 225,
                    "end": 229,
                    "text": "(79)",
                    "ref_id": "BIBREF53"
                },
                {
                    "start": 286,
                    "end": 290,
                    "text": "-179",
                    "ref_id": null
                },
                {
                    "start": 326,
                    "end": 330,
                    "text": "(80)",
                    "ref_id": "BIBREF54"
                },
                {
                    "start": 333,
                    "end": 336,
                    "text": "180",
                    "ref_id": "BIBREF156"
                }
            ],
            "ref_spans": [],
            "section": "INTRODUCTION 52 53"
        },
        {
            "text": "The fixed combination lopinavir/ritonavir has been widely used for the treatment of adults 183 living with HIV. Lopinavir has a molecular mass of 1349.7g/mol, is practically insoluble in 184 water and has a protein binding rate of 98-99%. Lopinavir is a protease inhibitor prescribed 185 in combination with ritonavir, an inhibitor of the isoform CYP3A4 of cytochrome p450 which 186 is used as a booster to obtain therapeutic plasma concentrations. It has in vitro and in vivo 187 efficiency against SARS-CoV-1 and MERS infections (81, 82) . It is considered as an option for 188 COVID-19 treatment in several trials, although the first randomized, open-label, controlled 189 study to be published reported no significant benefit of lopinavir/ritonavir (83) . 190",
            "cite_spans": [
                {
                    "start": 531,
                    "end": 535,
                    "text": "(81,",
                    "ref_id": "BIBREF55"
                },
                {
                    "start": 536,
                    "end": 539,
                    "text": "82)",
                    "ref_id": "BIBREF56"
                },
                {
                    "start": 753,
                    "end": 757,
                    "text": "(83)",
                    "ref_id": "BIBREF57"
                }
            ],
            "ref_spans": [],
            "section": "Lopinavir/Ritonavir 182"
        },
        {
            "text": "The tolerability of lopinavir/ritonavir is poorer than for other HIV protease inhibitors, espe-191 cially regarding digestive disorders and lipid abnormalities (84) . In the randomized controlled 192 trial from China in adults with severe Covid-19 infection (83), treatment (400mg/100mg 193 twice a day) had to be stopped early for 13.8% (n=13) of patients because of adverse events 194 (primarily gastrointestinal adverse events). This incidence of severe adverse events was 195 higher than reported in HIV infection at the same dose. Lopinavir/ritonavir exposure in -196 creases plasma concentrations of CYP 3A4 metabolized drug taken concurrently . 197 In pregnant women living with HIV, lopinavir/ritonavir was for several years the most widely-198 used antiretroviral therapy, with a nucleoside reverse transcriptase backbone (85) , as well as 199 in monotherapy (at 400mg/100mg, twice daily) (86) . During pregnancy, the clearance of the 200 free form of lopinavir / ritonavir is not changed and experts do not recommend increasing 201 the dosage of the drug (generally 400mg of lopinavir/100 mg of ritonavir b.i.d.) (87) . Lop-202 inavir/ritonavir crosses the placenta but poorly. Fetal transfer rates with perfused cotyledon 203 model are around 20 to 25% (88) and level in cord blood is undetectable in studies with 204 cord-to-mother ratios (89, 90) . This is due to strong protein binding for protease inhibitors 205 and to the efflux mechanism of the placental membrane transporters and in particular to P-206 glycoprotein (91) (92) (93) . 207",
            "cite_spans": [
                {
                    "start": 160,
                    "end": 164,
                    "text": "(84)",
                    "ref_id": "BIBREF58"
                },
                {
                    "start": 568,
                    "end": 572,
                    "text": "-196",
                    "ref_id": null
                },
                {
                    "start": 650,
                    "end": 655,
                    "text": ". 197",
                    "ref_id": null
                },
                {
                    "start": 831,
                    "end": 835,
                    "text": "(85)",
                    "ref_id": "BIBREF59"
                },
                {
                    "start": 846,
                    "end": 852,
                    "text": "as 199",
                    "ref_id": null
                },
                {
                    "start": 898,
                    "end": 902,
                    "text": "(86)",
                    "ref_id": "BIBREF60"
                },
                {
                    "start": 1123,
                    "end": 1127,
                    "text": "(87)",
                    "ref_id": "BIBREF61"
                },
                {
                    "start": 1264,
                    "end": 1268,
                    "text": "(88)",
                    "ref_id": "BIBREF62"
                },
                {
                    "start": 1351,
                    "end": 1355,
                    "text": "(89,",
                    "ref_id": "BIBREF63"
                },
                {
                    "start": 1356,
                    "end": 1359,
                    "text": "90)",
                    "ref_id": "BIBREF64"
                },
                {
                    "start": 1535,
                    "end": 1539,
                    "text": "(91)",
                    "ref_id": "BIBREF65"
                },
                {
                    "start": 1540,
                    "end": 1544,
                    "text": "(92)",
                    "ref_id": "BIBREF66"
                },
                {
                    "start": 1545,
                    "end": 1549,
                    "text": "(93)",
                    "ref_id": "BIBREF67"
                }
            ],
            "ref_spans": [],
            "section": "Lopinavir/Ritonavir 182"
        },
        {
            "text": "Pregnancy outcomes were reported to be similar to control women living with HIV (19, 20) . 208",
            "cite_spans": [
                {
                    "start": 80,
                    "end": 84,
                    "text": "(19,",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 85,
                    "end": 88,
                    "text": "20)",
                    "ref_id": "BIBREF21"
                }
            ],
            "ref_spans": [],
            "section": "Lopinavir/Ritonavir 182"
        },
        {
            "text": "There was no increase in the rate of congenital malformations after first-trimester exposure. 209 A large randomized trial has shown a higher rate of preterm births in the groups treated with 210 lopinavir/ritonavir-based ART as compared to monotherapy of zidovudine (94) . This has al-211 ready been described in a randomized trial comparing lopinavir/ritonavir-based ART to a 212 combination of 3 nucleoside reverse transcriptase inhibitors (95) . 213",
            "cite_spans": [
                {
                    "start": 267,
                    "end": 271,
                    "text": "(94)",
                    "ref_id": "BIBREF68"
                },
                {
                    "start": 443,
                    "end": 447,
                    "text": "(95)",
                    "ref_id": "BIBREF69"
                }
            ],
            "ref_spans": [],
            "section": "Lopinavir/Ritonavir 182"
        },
        {
            "text": "In addition, several cases of lopinavir/ritonavir toxicity have been described in treated pre-214 term infants, in particular signs suggesting adrenal insufficiency with hyponatremia and hy-215 perkalemia (96) . These undesirable effects led in 2011 to an alert by the FDA and to the con-216 traindicated of this association in premature babies (84) . 217 218",
            "cite_spans": [
                {
                    "start": 205,
                    "end": 209,
                    "text": "(96)",
                    "ref_id": "BIBREF70"
                },
                {
                    "start": 345,
                    "end": 349,
                    "text": "(84)",
                    "ref_id": "BIBREF58"
                }
            ],
            "ref_spans": [],
            "section": "Lopinavir/Ritonavir 182"
        },
        {
            "text": "Remdesivir (GS-5734) is a prodrug of a nucleoside analog antiviral. It has a molecular mass of 220 602.9 g/mol with a protein binding rate of 85-92 % in animal studies. It is metabolized by the 221 liver and has a renal and biliary excretion. Its water solubility is not yet available on the Pub-222",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Remdesivir 219"
        },
        {
            "text": "Chem website. It is metabolized into its active form GS-441524. It competes with ATP and 223",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Remdesivir 219"
        },
        {
            "text": "inhibits the viral RNA-polymerase (97) . Remdesivir was initially developed against Ebola vi-224 rus, with efficacy in a clinical phase III trial study (98) . It has also been studied to treat MERS-225",
            "cite_spans": [
                {
                    "start": 34,
                    "end": 38,
                    "text": "(97)",
                    "ref_id": "BIBREF71"
                },
                {
                    "start": 152,
                    "end": 156,
                    "text": "(98)",
                    "ref_id": "BIBREF72"
                }
            ],
            "ref_spans": [],
            "section": "Remdesivir 219"
        },
        {
            "text": "CoV and SARS-CoV-1 coronavirus infections (99) . Its efficacy against SARS-CoV-2 has been 226 proven in vitro (45,100) with IC50 of 11.41 o 6.25\u03bcM associated with emetine (21, 22) and in 227 vivo in animals (101) . Its mechanisms of action (shortening of the DNA chain or modification 228 of excision activity) remain to be explained in detail (99, 102) . A number of clinical trials are 229 underway to determine the efficacy and safety of remdesivir to treat COVID-19 230 (NCT04252664, NCT04257656, NCT04280705, NCT04292730, NCT04292899). \"Two double-231 blinded randomized clinical trials have been published using an intravenous loading dose of 232 200 mg followed by 100 mg daily for 10 days (103, 104) . Both showed a reduction of time to 233 clinical improvement (103) . Similar results have been reported in compassionate use for se-234 vere patients (105) .\" 235",
            "cite_spans": [
                {
                    "start": 42,
                    "end": 46,
                    "text": "(99)",
                    "ref_id": "BIBREF73"
                },
                {
                    "start": 171,
                    "end": 175,
                    "text": "(21,",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 176,
                    "end": 179,
                    "text": "22)",
                    "ref_id": "BIBREF23"
                },
                {
                    "start": 207,
                    "end": 212,
                    "text": "(101)",
                    "ref_id": "BIBREF75"
                },
                {
                    "start": 344,
                    "end": 348,
                    "text": "(99,",
                    "ref_id": "BIBREF73"
                },
                {
                    "start": 349,
                    "end": 353,
                    "text": "102)",
                    "ref_id": "BIBREF76"
                },
                {
                    "start": 697,
                    "end": 702,
                    "text": "(103,",
                    "ref_id": "BIBREF77"
                },
                {
                    "start": 703,
                    "end": 707,
                    "text": "104)",
                    "ref_id": "BIBREF78"
                },
                {
                    "start": 770,
                    "end": 775,
                    "text": "(103)",
                    "ref_id": "BIBREF77"
                },
                {
                    "start": 859,
                    "end": 864,
                    "text": "(105)",
                    "ref_id": "BIBREF79"
                }
            ],
            "ref_spans": [],
            "section": "Remdesivir 219"
        },
        {
            "text": "To date, tolerance data in humans are sparse. There is a risk of renal dysfunction (106-108) 236 and elevated liver enzymes, and a possible effect on mitochondrial functions (106), as well 237 as a case of cardiac arrest in a clinical trial on Ebola infection (98) . Thus, investigators rec-238 ommended biological monitoring of liver and kidney functions. \"Clinical trials in COVID-19 239 disease also report adverse effects with an incidence ranging from 21 to 66 %\" (103) (104) (105) . 240",
            "cite_spans": [
                {
                    "start": 260,
                    "end": 264,
                    "text": "(98)",
                    "ref_id": "BIBREF72"
                },
                {
                    "start": 469,
                    "end": 474,
                    "text": "(103)",
                    "ref_id": "BIBREF77"
                },
                {
                    "start": 475,
                    "end": 480,
                    "text": "(104)",
                    "ref_id": "BIBREF78"
                },
                {
                    "start": 481,
                    "end": 486,
                    "text": "(105)",
                    "ref_id": "BIBREF79"
                }
            ],
            "ref_spans": [],
            "section": "Remdesivir 219"
        },
        {
            "text": "Regarding pregnant women, 6 women who were treated with remdesivir in a clinical study 241 on Ebola disease had positive pregnancy tests (98) , but these cases were not described. We 242 found no study addressing the safety of remdesivir in pregnant women, nor its placental 243 transfer. Considering its small molecular weight and its high protein-binding rate, we may 244 expect that remdesivir crosses the placenta. Oseltamivir is widely recommended to treat influenza in children or adults considered at risk 251 of severe manifestations, including pregnant women. According to the ex vivo human pla-252 cental perfusion, oseltamivir and its metabolite oseltamivir carboxylate, cross poorly the 253 placenta with transfer rates of 12.39 and 10.17% respectively (111) . Retrospective study 254 with large population do not provide evidence of risk of any major congenital malformation 255 nor in heart defect (112) . No evidence of increased risk of preterm birth nor small for gesta-256 tional age infants was reported in another prospective study (112, 113) . We did not find any 257 information about pregnancy and zanamivir, another neuraminidase inhibitor. 258",
            "cite_spans": [
                {
                    "start": 137,
                    "end": 141,
                    "text": "(98)",
                    "ref_id": "BIBREF72"
                },
                {
                    "start": 765,
                    "end": 770,
                    "text": "(111)",
                    "ref_id": "BIBREF85"
                },
                {
                    "start": 912,
                    "end": 917,
                    "text": "(112)",
                    "ref_id": "BIBREF86"
                },
                {
                    "start": 1052,
                    "end": 1057,
                    "text": "(112,",
                    "ref_id": "BIBREF86"
                },
                {
                    "start": 1058,
                    "end": 1062,
                    "text": "113)",
                    "ref_id": "BIBREF87"
                }
            ],
            "ref_spans": [],
            "section": "Remdesivir 219"
        },
        {
            "text": "Favipiravir is an antiviral drug approved in Japan and China for influenza which inhibits the 259 RNA polymerase enzyme (114, 115) . It has shown efficacy against Ebola virus in animals and 260",
            "cite_spans": [
                {
                    "start": 120,
                    "end": 125,
                    "text": "(114,",
                    "ref_id": "BIBREF88"
                },
                {
                    "start": 126,
                    "end": 130,
                    "text": "115)",
                    "ref_id": "BIBREF89"
                }
            ],
            "ref_spans": [],
            "section": "Remdesivir 219"
        },
        {
            "text": "humans (116, 117) . A potential synergistic benefit of favipiravir associated with oseltamivir 261 has been described in influenza (118) (119) . Favipiravir is under investigation for treating 262 SARS-CoV-2 in several clinical trials (NCT04310228, NCT04358549). We found no information 263 about the use of favipiravir in pregnant women but caution is needed because of a warning 264 by the Japanese drug agency on a teratogenic risk in preclinical animal studies (114, 120) . 265",
            "cite_spans": [
                {
                    "start": 7,
                    "end": 12,
                    "text": "(116,",
                    "ref_id": "BIBREF90"
                },
                {
                    "start": 13,
                    "end": 17,
                    "text": "117)",
                    "ref_id": "BIBREF91"
                },
                {
                    "start": 131,
                    "end": 136,
                    "text": "(118)",
                    "ref_id": "BIBREF92"
                },
                {
                    "start": 137,
                    "end": 142,
                    "text": "(119)",
                    "ref_id": "BIBREF93"
                },
                {
                    "start": 465,
                    "end": 470,
                    "text": "(114,",
                    "ref_id": "BIBREF88"
                },
                {
                    "start": 471,
                    "end": 475,
                    "text": "120)",
                    "ref_id": "BIBREF94"
                }
            ],
            "ref_spans": [],
            "section": "Remdesivir 219"
        },
        {
            "text": "The combination of alpha-interferon and ribavirin (an antiviral mainly used to treat hepatitis 266 C) is also under investigation in COVID-19, even though it has not been proven to reduce 267 mortality for the treatment of MERS-CoV (121, 122) . In pregnant women, ribavirin is usually 268 mations. However, the use of boosted protease inhibitors has been associated with an in-276 creased risk of preterm delivery, although it is not clear whether the impact is related to any 277 specific drug or to other confounding factors (124) . Nelfinavir is a selective inhibitor of HIV 278 protease which has been reported to inhibit replication of SARS-CoV replication in vitro 279 (125) . The placental transfer of nelfinavir is low (90) . There is no increase in the risk of con-280 genital malformations. 281",
            "cite_spans": [
                {
                    "start": 232,
                    "end": 237,
                    "text": "(121,",
                    "ref_id": "BIBREF95"
                },
                {
                    "start": 238,
                    "end": 242,
                    "text": "122)",
                    "ref_id": "BIBREF96"
                },
                {
                    "start": 527,
                    "end": 532,
                    "text": "(124)",
                    "ref_id": "BIBREF98"
                },
                {
                    "start": 675,
                    "end": 680,
                    "text": "(125)",
                    "ref_id": "BIBREF99"
                },
                {
                    "start": 727,
                    "end": 731,
                    "text": "(90)",
                    "ref_id": "BIBREF64"
                }
            ],
            "ref_spans": [],
            "section": "Remdesivir 219"
        },
        {
            "text": "Arbidol hydrochloride (umifenovir) is an immunomodulator and a broad-spectrum antiviral 282 drug. Arbidol is able to block viral fusion against influenza viruses and has been reported to 283 have antiviral in vitro activity against SARS-CoV (126). It has been reported to increase the 284 effect of lopinavir/ritonavir treatment on SARS-CoV-2 excretion at 7 and 14 days in a retro-285 spective cohort study (n=33 patients) (127), but clinical outcomes have not yet been as-286 sessed (128) . Arbidol is under investigation in a randomized controlled phase 4 study, com-287 pared to lopinavir/ritonavir, and to oseltamivir (NCT04255017). A study reports its use, in 288 association with others antiviral drugs, in 7 pregnant women with SARS-CoV-2 infection 289 (129) . We found no information on safety of umifenovir in pregnancy. sheep with limited fetal exposure (130) . Data on safety for pregnant women and neonates 297 are sparse and a recent meta-analysis has concluded to insufficient evidence for its safety 298 profile in pregnancy (131) . Nitazoxanide is another antiparasitic drug under consideration 299 (NCT04343989) for which we found no specific data on specific use in pregnant women. 300",
            "cite_spans": [
                {
                    "start": 484,
                    "end": 489,
                    "text": "(128)",
                    "ref_id": "BIBREF103"
                },
                {
                    "start": 760,
                    "end": 765,
                    "text": "(129)",
                    "ref_id": "BIBREF104"
                },
                {
                    "start": 864,
                    "end": 869,
                    "text": "(130)",
                    "ref_id": "BIBREF105"
                },
                {
                    "start": 1040,
                    "end": 1045,
                    "text": "(131)",
                    "ref_id": "BIBREF106"
                }
            ],
            "ref_spans": [],
            "section": "Remdesivir 219"
        },
        {
            "text": "The FDA-approved antihelminthic drug niclosamide has shown in vitro antiviral efficacy 301 against SARS-Cov-2 (22). As mentioned above, the amebicide emetine inhibit SARS-CoV-2 302",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Remdesivir 219"
        },
        {
            "text": "replication (21, 22) and has been studied in association with remdesivir.\" 303 304 Interferon 305",
            "cite_spans": [
                {
                    "start": 12,
                    "end": 16,
                    "text": "(21,",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 17,
                    "end": 20,
                    "text": "22)",
                    "ref_id": "BIBREF23"
                }
            ],
            "ref_spans": [],
            "section": "Remdesivir 219"
        },
        {
            "text": "Interferon beta and lambda are both studied as COVID-19 therapy but most information 306 concerns interferon beta. Interferon beta is a cytokine with antiviral, anti-proliferative and 307 immunomodulatory activities. It is commonly used to treat multiple sclerosis. It is a glyco-308 protein that works after it has attached to the cell membrane by triggering a cascade of in-309 tracellular signaling with in particular the induction of enzymes which could inhibit viral rep-310 lication in infected cells. Interferon beta has been proposed as immune-modulatory treat-311 ment to control the massive inflammation resulting in lung injury in SARS-CoV-2 infection. 312",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Remdesivir 219"
        },
        {
            "text": "There is a long experience of safety and tolerability of interferon in non-pregnant adults and 313 the most frequently reported adverse events are injection site reactions, asthenia, flu-like 314 symptoms, headache and lymphopenia (132) . 315",
            "cite_spans": [
                {
                    "start": 231,
                    "end": 236,
                    "text": "(132)",
                    "ref_id": "BIBREF107"
                }
            ],
            "ref_spans": [],
            "section": "Remdesivir 219"
        },
        {
            "text": "Pregnancy outcomes in women treated with interferon beta have been documented in pro-316 spective and retrospective pharmacovigilance studies on 1348 and 99948 pregnant women, 317 respectively (133) (134) (135) . The prescribed subcutaneous doses ranged from 30 \u03bcg/0.5mL/week 318 to 30 \u03bcg/0.5mL three times a week. These studies did not find an increased risk of miscar-319 riage or congenital malformation associated with treatment with beta interferon. Other per-320 inatal outcomes were not described. 321",
            "cite_spans": [
                {
                    "start": 193,
                    "end": 198,
                    "text": "(133)",
                    "ref_id": "BIBREF108"
                },
                {
                    "start": 199,
                    "end": 204,
                    "text": "(134)",
                    "ref_id": "BIBREF109"
                },
                {
                    "start": 205,
                    "end": 210,
                    "text": "(135)",
                    "ref_id": "BIBREF110"
                }
            ],
            "ref_spans": [],
            "section": "Remdesivir 219"
        },
        {
            "text": "We did not find any study on the transplacental passage of interferon beta. However, inter-322 ferons have high molecular weights and it has been shown that interferon alpha does not 323 cross the placenta in humans, according to data in the ex vivo cotyledon perfusion model 324 (136, 137) as well as neonatal cord blood samples (138) . By analogy, we can assume that be-325 ta interferon does not cross the placental barrier. 326 327",
            "cite_spans": [
                {
                    "start": 280,
                    "end": 285,
                    "text": "(136,",
                    "ref_id": "BIBREF111"
                },
                {
                    "start": 286,
                    "end": 290,
                    "text": "137)",
                    "ref_id": null
                },
                {
                    "start": 330,
                    "end": 335,
                    "text": "(138)",
                    "ref_id": "BIBREF114"
                }
            ],
            "ref_spans": [],
            "section": "Remdesivir 219"
        },
        {
            "text": "Transfusion of immunoglobulins from patients who have recovered from the disease is a 329 passive immunotherapy. Convalescent plasma transfusion has been previously described as 330 a therapeutic option in management of Ebola and previous coronavirus infections (139, 140) . 331",
            "cite_spans": [
                {
                    "start": 262,
                    "end": 267,
                    "text": "(139,",
                    "ref_id": "BIBREF115"
                },
                {
                    "start": 268,
                    "end": 272,
                    "text": "140)",
                    "ref_id": "BIBREF116"
                }
            ],
            "ref_spans": [],
            "section": "Convalescent plasma 328"
        },
        {
            "text": "It was not associated with a significant improvement in survival in Ebola patients (141) safety (150) . Even fewer data are available regarding sarilumab/siltuximab. As other immu-371 noglobulin G antibodies of the IgG 1 subclass, they cross the placenta. Immune response may 372 be impaired in infants exposed in utero. A registry has been established to monitor out-373 comes following exposure to anti-IL6 monoclonals during pregnancy. \"Other anti-interleukin 374 inhibitors (anti-IL1) also under study are canakinumab (NCT 04362813) and anakinra (NCT 375 04362813). A retrospective study in 31 exposed-women has reported global sparse reassur-376 ing data with no neonatal infection but renal agenesis in one fetus after anakinra exposition 377 (151) .\" 378",
            "cite_spans": [
                {
                    "start": 96,
                    "end": 101,
                    "text": "(150)",
                    "ref_id": "BIBREF126"
                },
                {
                    "start": 749,
                    "end": 754,
                    "text": "(151)",
                    "ref_id": "BIBREF127"
                }
            ],
            "ref_spans": [],
            "section": "Convalescent plasma 328"
        },
        {
            "text": "The sphingosine-1-phosphate receptor regulator fingolimod (FTY720) is an immune modula-379 tor which prevents lymphocytes contribution to autoimmune reaction. It also has been pro-380 posed in COVID-19 therapy (NCT 04280588). Fingolimod has been widely used in severe mul-381 tiple sclerosis. It is generally well-tolerated and has a long term safety profile (including in-382 fection or malignancy rates) (152,153) but serious cardiac adverse effects have been report-383 ed in patients at risk of heart failure. Data on the safety in pregnant women do not show any 384 increase in major malformation rates among live births in comparison with the general 385 population and the multiple-sclerosis population (n=91 pregnancies and 75 live births) (154) . 386",
            "cite_spans": [
                {
                    "start": 748,
                    "end": 753,
                    "text": "(154)",
                    "ref_id": "BIBREF130"
                }
            ],
            "ref_spans": [],
            "section": "Convalescent plasma 328"
        },
        {
            "text": "We found no data on placental transfer of fingolimod. 387",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Convalescent plasma 328"
        },
        {
            "text": "Baricitinib, an anti-JAK and anti-AAK1 inhibitor was found capable to reduce or interrupt the 388 passage of the virus into target cells (endocytosis into pulmonary cell), and to inhibit the 389 JAK1-and JAK2-mediated cytokine release, constituting the rationale to perform a trial on 390 patients with mild to moderate COVID-19 (2, 155) . The drug was licensed for the treatment 391 of rheumatoid arthritis at the daily dose of 4 mg/orally, with excellent results in terms of 392 clinical response and a good safety profile (155) . Since baricitinib does not interact with anti-393 virals due to its prevalent renal elimination, it may be used in combination with antiviral 394 therapy. As biologic and small molecule, baricitinib is contraindicated in pregnancy awaiting 395 larger studies to assess its safety (156) (157) . Another anti-JAK molecules is also tested in 396 current studies, ruxolitinib (NCT04377620, NCT04334044, NCT04334044). 397",
            "cite_spans": [
                {
                    "start": 329,
                    "end": 332,
                    "text": "(2,",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 333,
                    "end": 337,
                    "text": "155)",
                    "ref_id": "BIBREF131"
                },
                {
                    "start": 525,
                    "end": 530,
                    "text": "(155)",
                    "ref_id": "BIBREF131"
                },
                {
                    "start": 819,
                    "end": 824,
                    "text": "(157)",
                    "ref_id": "BIBREF133"
                }
            ],
            "ref_spans": [],
            "section": "Convalescent plasma 328"
        },
        {
            "text": "Infliximab is also under consideration for severe covid-19 pneumoniae (NCT04333420). 398",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Convalescent plasma 328"
        },
        {
            "text": "There are data from retrospective cohorts on the safety of infliximab in pregnant women 399 treated for Crohn's disease (158) . It crosses the placenta in the second and third trimester 400 and has been detected in newborn samples six months after delivery (159, 160) . 401 \"Leflunomide is an immune suppressor used in rheumatoid arthritis which is also under 402 study for COVID-19 (NCT 04361214). It is teratogenic in an animal model and thus is to be 403 avoided if possible, although a small retrospective study (164) reported no association with 404 major congenital malformation after 5 cases of first trimester exposure, nor adverse preg-405 nancy outcomes after 15 second and third trimester exposures. We found no data on pla-406 cental transfer of leflunomide. 407",
            "cite_spans": [
                {
                    "start": 120,
                    "end": 125,
                    "text": "(158)",
                    "ref_id": "BIBREF134"
                },
                {
                    "start": 257,
                    "end": 262,
                    "text": "(159,",
                    "ref_id": "BIBREF135"
                },
                {
                    "start": 263,
                    "end": 267,
                    "text": "160)",
                    "ref_id": "BIBREF136"
                },
                {
                    "start": 516,
                    "end": 521,
                    "text": "(164)",
                    "ref_id": "BIBREF140"
                }
            ],
            "ref_spans": [],
            "section": "Convalescent plasma 328"
        },
        {
            "text": "Additional immune therapies under study to treat the cytokine storm in COVID-19 include 408 lenzilumab, a humanized monoclonal antibody that blocks the granulocyte-macrophage 409 colony stimulating factor (GM-CSF) (NCT 04351152) and the human IgG1 monoclonal anti-410 body gimsilumab (NCT 04351243). 411",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Convalescent plasma 328"
        },
        {
            "text": "Colchicine is a powerful anti-inflammatory drug. It is under study in a simple, pragmatic ran-412 domized controlled trial for its immunomodulatory and anti-inflammatory effects, which 413 may reduce the cytokine storm and inflammatory cascade activation in severe forms of 414 COVID-19 (NCT 04328480, NCT04326790). To date, it has not been proved to be effective as 415 treatment or as prevention of COVID-19 disease (161) (162) (163) .Colchicine has been approved for 416 the treatment of various inflammatory diseases such as gout, Familial Mediterranean Fever, 417",
            "cite_spans": [
                {
                    "start": 418,
                    "end": 423,
                    "text": "(161)",
                    "ref_id": "BIBREF137"
                },
                {
                    "start": 424,
                    "end": 429,
                    "text": "(162)",
                    "ref_id": "BIBREF138"
                },
                {
                    "start": 430,
                    "end": 435,
                    "text": "(163)",
                    "ref_id": "BIBREF139"
                }
            ],
            "ref_spans": [],
            "section": "Convalescent plasma 328"
        },
        {
            "text": "Bechet disease and some dermatologic indications (chronic urticaria, cutaneous vasculitis 418 and psoriasis). Regarding pregnant women, colchicine is not contra indicated during preg-419 nancy (150) . Colchicine crosses the placenta (164) . A meta-analysis shows no increase inci-420 dence of miscarriage or major fetal malformations in exposed women compared to non- ",
            "cite_spans": [
                {
                    "start": 193,
                    "end": 198,
                    "text": "(150)",
                    "ref_id": "BIBREF126"
                },
                {
                    "start": 233,
                    "end": 238,
                    "text": "(164)",
                    "ref_id": "BIBREF140"
                }
            ],
            "ref_spans": [],
            "section": "Convalescent plasma 328"
        },
        {
            "text": "patients (NCT04318418). Another angiotensin receptor blocker telmisartan is also being 446 studied (NCT 04355936).In pregnancy, drugs that block the renin-angiotensin system can 447 damage the fetal kidneys, leading to renal failure with oligohydramnios, deformations and 448 lung hypoplasia (174, 175) . These drugs modifying the renin-angiotensin cascade could also 449 impact placental functions leading to growth retardation (176) . and visual disturbance (188) . It crosses the placenta at a high rate in ex vivo model (189) and 457 it is thus considered in antenatal care to prevent pulmonary hypertension in case of congeni-458 tal diaphragmatic hernia (190) . Sildenafil has also been studied for the prevention of fetal 459 growth restriction in case of maternal vascular disease such as pre-eclampsia and a meta-460 analysis has shown a significant increase in fetal weight at birth (191) . No increases of neo-461 natal death or congenital anomalies have been described in another meta-analysis (188) . 462",
            "cite_spans": [
                {
                    "start": 292,
                    "end": 297,
                    "text": "(174,",
                    "ref_id": "BIBREF150"
                },
                {
                    "start": 298,
                    "end": 302,
                    "text": "175)",
                    "ref_id": "BIBREF151"
                },
                {
                    "start": 429,
                    "end": 434,
                    "text": "(176)",
                    "ref_id": "BIBREF152"
                },
                {
                    "start": 460,
                    "end": 465,
                    "text": "(188)",
                    "ref_id": "BIBREF164"
                },
                {
                    "start": 524,
                    "end": 529,
                    "text": "(189)",
                    "ref_id": "BIBREF165"
                },
                {
                    "start": 660,
                    "end": 665,
                    "text": "(190)",
                    "ref_id": "BIBREF166"
                },
                {
                    "start": 893,
                    "end": 898,
                    "text": "(191)",
                    "ref_id": "BIBREF167"
                },
                {
                    "start": 1006,
                    "end": 1011,
                    "text": "(188)",
                    "ref_id": "BIBREF164"
                }
            ],
            "ref_spans": [],
            "section": "SARSCoV-2. Losartan, an angiotensin II receptor blocker (ARB) is under study in COVID-19 445"
        },
        {
            "text": "However, the STRIDER group (Sildenafil TheRapy In Dismal prognosis Early-onset intrauterine 463 growth Restriction) which was gathered in 2011 to explore effects of sildenafil in fetal 464 growth restriction recommended against the prescription of sildenafil (192, 193) . 465",
            "cite_spans": [
                {
                    "start": 259,
                    "end": 264,
                    "text": "(192,",
                    "ref_id": "BIBREF168"
                },
                {
                    "start": 265,
                    "end": 269,
                    "text": "193)",
                    "ref_id": "BIBREF169"
                }
            ],
            "ref_spans": [],
            "section": "SARSCoV-2. Losartan, an angiotensin II receptor blocker (ARB) is under study in COVID-19 445"
        },
        {
            "text": "cancer in pregnancy with no maternal and fetal adverse effects (177) but it is still recom-467 mend to avoid its use (178) . It has also been used during pregnancy to treat intravitreal 468 hemorrhage with local injection (179, 180) with neither no pregnancy-related complications. 469",
            "cite_spans": [
                {
                    "start": 117,
                    "end": 122,
                    "text": "(178)",
                    "ref_id": "BIBREF154"
                },
                {
                    "start": 222,
                    "end": 227,
                    "text": "(179,",
                    "ref_id": "BIBREF155"
                },
                {
                    "start": 228,
                    "end": 232,
                    "text": "180)",
                    "ref_id": "BIBREF156"
                }
            ],
            "ref_spans": [],
            "section": "Bevacizumab (NCT 04305106) is an anti-VEGF antibody. It has been used in cases of ovarian 466"
        },
        {
            "text": "We found no information on the placental transfer of bevacizumab. 470 471",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Bevacizumab (NCT 04305106) is an anti-VEGF antibody. It has been used in cases of ovarian 466"
        },
        {
            "text": "Thalidomide is under consideration for COVID-19 (NCT04273529 and NCT04273581), but it is 473 definitively contraindicated in pregnancy because of its proven teratogenicity (181, 182) . 474",
            "cite_spans": [
                {
                    "start": 172,
                    "end": 177,
                    "text": "(181,",
                    "ref_id": "BIBREF157"
                },
                {
                    "start": 178,
                    "end": 182,
                    "text": "182)",
                    "ref_id": "BIBREF158"
                }
            ],
            "ref_spans": [],
            "section": "Anti-cancer agents 472"
        },
        {
            "text": "There is no information on pregnancy use, but in view of its high molecular mass (1110 476 g/mol), we may expect that it would not cross the placenta. 477",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Another anti-cancer agent, plitidepsin is also under study for COVID-19 (NCT 04382066). 475"
        },
        {
            "text": "The topoisomerase II blocker etoposide, which is proposed for a clinical study in COVID-19 478 (NCT 04356690) has been reported in few case reports to treat gestational trophoblastic 479 disease or malignant teratomas (183) (184) (185) . Data on exposure during completed pregnancy 480 are sparse (186) and evidence of adverse effect is difficult to conclude because women re-481 ceived combinations of drugs. We found no data on placental transfer of etoposide. 482",
            "cite_spans": [
                {
                    "start": 218,
                    "end": 223,
                    "text": "(183)",
                    "ref_id": "BIBREF159"
                },
                {
                    "start": 224,
                    "end": 229,
                    "text": "(184)",
                    "ref_id": "BIBREF160"
                },
                {
                    "start": 230,
                    "end": 235,
                    "text": "(185)",
                    "ref_id": "BIBREF161"
                }
            ],
            "ref_spans": [],
            "section": "Another anti-cancer agent, plitidepsin is also under study for COVID-19 (NCT 04382066). 475"
        },
        {
            "text": "A large variety of other drugs are also currently under consideration against SARS-CoV-2. 484",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Other approaches 483"
        },
        {
            "text": "Dapagliflozin is an antidiabetic medication of the sodium-glucose co-transporter 2 (SGLT2) 485 inhibitor class which is under consideration to treat COVID-19 respiratory failure, sepsis and 486 multi-organ failure in a clinical trial (NCT 04350593). We found no specific data on its use 487 during pregnancy. safety data for use of colchicine, steroids, oseltamivir and azithromycin, as well as to some 499 extent monoclonals such as Infliximab and possibly tocilizumab. Some drugs are strictly pro-500 hibited in pregnancy due to known teratogenicity (thalidomide) or fetal toxicities (renin-501 angiotensin system blockers). Other candidates have insufficient pregnancy data, including 502 IL-6 inhibitors, umifenovir, and favipiravir. Importantly, remdesivir remains an investigational 503 drug with restricted use in the absence of preclinical data concerning pregnancy in view of 504 its toxicity profile (hypotension during injection, renal and liver dysfunction). The range of 505 medications under consideration to treat COVID-19 is rapidly evolving. 506",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Other approaches 483"
        },
        {
            "text": "An unusual aspect of clinical trials in COVID-19 is the fact that most of the drugs under inves-507 tigation are repurposed and thus are already used in pregnant women for their established 508",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Other approaches 483"
        },
        {
            "text": "indications. Because pregnant women are usually excluded from clinical trials, such pregnan-509 cy follow-up was obtained from off-label use. While some follow-up is obtained from struc-510 tured cohort studies, most studies are from retrospective registers with limited endpoints 511 and delayed and disparate collection of clinical data. Importantly, the doses used may differ 512 and the diseases treated differ widely, so that drug toxicities may be quite different. This is 513 of particular concern in patients with severe (multi-)organ failure. 514",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Other approaches 483"
        },
        {
            "text": "The use of medications in pregnancy must take into account a number of important issues. 515",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Other approaches 483"
        },
        {
            "text": "First, there is potential for increased toxicities to the patient herself, pharmacokinetic and 516 pharmacodynamic differences with non-pregnant individuals. Physiological changes include 517 increased volume of distribution, lower albumin concentrations and hormone-induced sus-518 ceptibility to hepatic toxicities (187) . Also, there may be an impact on placental functions 519 and potential adverse pregnancy outcomes, such as abortion, fetal growth restriction or pre-520 term delivery. Most important are the potential risks for the fetus, including teratogenicity, 521 fetal toxicities and long-term impact on the child's health. 522",
            "cite_spans": [
                {
                    "start": 317,
                    "end": 322,
                    "text": "(187)",
                    "ref_id": "BIBREF163"
                }
            ],
            "ref_spans": [],
            "section": "Other approaches 483"
        },
        {
            "text": "Clinical trials usually exclude pregnant women and newborns even when benefits are ex-523 pected for this population type. This precautionary principle has been denounced as unjust 524 (188) . Pregnant women, according to the principle of autonomy, should be able to take re-525 sponsibility and provide consent for participation in clinical trials (189) ; even for drugs with 526 potential teratogenic risk (190) . Mostly excluding pregnant women from clinical trials pre-527 vents us from obtaining reliable safety data from the use of drugs during pregnancy. This 528 makes it very difficult to take care of pregnant patients with the prescription of drugs with-529 out proof of efficacy or tolerance established during pregnancy. It thus appears that the 530 benefits of including pregnant patients in therapeutic trials would outweigh the risks (191) . 531",
            "cite_spans": [
                {
                    "start": 185,
                    "end": 190,
                    "text": "(188)",
                    "ref_id": "BIBREF164"
                },
                {
                    "start": 349,
                    "end": 354,
                    "text": "(189)",
                    "ref_id": "BIBREF165"
                },
                {
                    "start": 408,
                    "end": 413,
                    "text": "(190)",
                    "ref_id": "BIBREF166"
                },
                {
                    "start": 850,
                    "end": 855,
                    "text": "(191)",
                    "ref_id": "BIBREF167"
                }
            ],
            "ref_spans": [],
            "section": "Other approaches 483"
        },
        {
            "text": "Knowledge about placental transfer should be available early enough in the process of drug 532 evaluation in order to be able to move on to use in pregnant women without needless de-533 lays. Most medications cross the placenta, but the amount of placental transfer differs. Pas-534 sive diffusion is the major mechanism of transplacental transfer and depends on pharmaco-535 kinetic parameters including small molecular weight, high water solubility, polarity, and im-536 portant protein-binding rate (>90%). The other important mechanism is active transport 537 which depends on import or export protein-transporters. Three types of studies have been 538 developed to obtain information on the fetal drug exposure. Placental transfer may be esti-539 mated by the concentration ratios between the umbilical cord blood and maternal blood at 540 birth. But these studies are based on small numbers of patients. Preclinical placental transfer 541 studies are performed either in animals but those placentas differ from the human hemo-542 chorial placenta, or from experimental models (192, 193) , including the ex vivo human coty-543 ledon perfusion model (2, 3, 4) . Physiologically-based pharmacokinetic models (PBPK) have 544 also been developed to predict the fetal exposure to drugs (196) 545",
            "cite_spans": [
                {
                    "start": 1082,
                    "end": 1087,
                    "text": "(192,",
                    "ref_id": "BIBREF168"
                },
                {
                    "start": 1088,
                    "end": 1092,
                    "text": "193)",
                    "ref_id": "BIBREF169"
                },
                {
                    "start": 1154,
                    "end": 1157,
                    "text": "(2,",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 1158,
                    "end": 1160,
                    "text": "3,",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 1161,
                    "end": 1163,
                    "text": "4)",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 1286,
                    "end": 1291,
                    "text": "(196)",
                    "ref_id": "BIBREF172"
                }
            ],
            "ref_spans": [],
            "section": "Other approaches 483"
        },
        {
            "text": "Since the available evidence suggests that there is little risk of vertical transmission of SARS-546",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Other approaches 483"
        },
        {
            "text": "CoV-2, there is no need for antiviral therapies to cross the placenta. Nor is there any benefit 547 to be expected from fetal exposure to immunomodulatory therapies. Thus, the optimal ap-548 proaches to treating pregnant women with COVID-19 would theoretically be those with min-549 imal fetal impact and/or minimal placental transfer. 550",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Other approaches 483"
        },
        {
            "text": "The management of pregnant women with COVID-19 is essentially symptomatic. Therapies 551 must be discussed, based on rapidly evolving data on the efficacy and safety in non-pregnant 552 adults, also taking into account obstetric and fetal consequences of such treatment, but also 553 of the consequences of lack of therapy. In severe cases, therapy should not be withheld sole-554 ly because of pregnancy, and should be discussed between obstetricians, intensive care and 555 infectious diseases as well as the patient and her partner. 556 Table 1 : Transplacental drug transfer in humans and safety data in women and neonates exposed to medications used for the treatment of COVID-19 patients ",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 540,
                    "end": 547,
                    "text": "Table 1",
                    "ref_id": null
                }
            ],
            "section": "Other approaches 483"
        },
        {
            "text": "No specific data on transplacental transfer Sinclair (199) ",
            "cite_spans": [
                {
                    "start": 53,
                    "end": 58,
                    "text": "(199)",
                    "ref_id": "BIBREF175"
                }
            ],
            "ref_spans": [],
            "section": "Ribavirin"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "D\u00e9claration sur la deuxi\u00e8me r\u00e9union du Comit\u00e9 d'urgence du R\u00e8glement sanitaire international",
            "authors": [],
            "year": 2005,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Coronavirus Disease 2019 (COVID-19) Pandemic and Pregnancy",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Dashraath",
                    "suffix": ""
                },
                {
                    "first": "Jing",
                    "middle": [],
                    "last": "Lin Jeslyn",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": "Mei",
                    "middle": [],
                    "last": "Xian Karen",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": "Li",
                    "middle": [],
                    "last": "Min",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": "Sarah",
                    "middle": [
                        "L"
                    ],
                    "last": "Biswas",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Am J Obstet Gynecol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Coronavirus Disease 2019 (COVID-19) and Pregnancy: What obstetricians need to know",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "A"
                    ],
                    "last": "Rasmussen",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "C"
                    ],
                    "last": "Smulian",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "A"
                    ],
                    "last": "Lednicky",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "S"
                    ],
                    "last": "Wen",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "J"
                    ],
                    "last": "Jamieson",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Am J Obstet Gynecol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Potential Maternal and Infant Outcomes from (Wuhan) Coronavirus 2019-nCoV Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "A"
                    ],
                    "last": "Schwartz",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "L"
                    ],
                    "last": "Graham",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Viruses. 2020",
            "volume": "10",
            "issn": "2",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "M"
                    ],
                    "last": "Siston",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "A"
                    ],
                    "last": "Rasmussen",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "A"
                    ],
                    "last": "Honein",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "M"
                    ],
                    "last": "Fry",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Seib",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "M"
                    ],
                    "last": "Callaghan",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "JAMA",
            "volume": "303",
            "issn": "15",
            "pages": "1517--1542",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Evidence and possible mechanisms of rare maternal-fetal transmission of SARS-CoV-2",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Egloff",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Vauloup-Fellous",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Picone",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Mandelbrot",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Roques",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Clin Virol Off Publ Pan Am Soc Clin Virol",
            "volume": "128",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Guo",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Luo",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Yu",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Lancet Lond Engl",
            "volume": "395",
            "issn": "",
            "pages": "809--824",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "An Analysis of 38 Pregnant Women with COVID-19, Their Newborn Infants, and Maternal-Fetal Transmission of SARS-CoV-2: Maternal Coronavirus Infections and Pregnancy Outcomes",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "A"
                    ],
                    "last": "Schwartz",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Arch Pathol Lab Med",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "Possible Vertical Transmission of SARS-CoV-2 From an Infected Mother to Her Newborn",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Dong",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Tian",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "He",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Zhu",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "JAMA",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "Antibodies in Infants Born to Mothers With COVID-19 Pneumonia",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Zeng",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Fan",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Tang",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Deng",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "JAMA",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "Can SARS-CoV-2 Infection Be Acquired In Utero?: More Definitive Evidence Is Needed",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "W"
                    ],
                    "last": "Kimberlin",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Stagno",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "JAMA",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "Neonatal Early-Onset Infection With SARS-CoV-2 in 33 Neonates Born to Mothers With COVID-19 in Wuhan, China. JAMA Pediatr",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Zeng",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Xia",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Yuan",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Yan",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Xiao",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Shao",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF15": {
            "ref_id": "b15",
            "title": "Gynecol Obstet Fertil Senol",
            "authors": [],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "Clinical analysis of pregnant women with 2019 novel coronavirus pneumonia",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Liao",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Shao",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Med Virol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF17": {
            "ref_id": "b17",
            "title": "Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Sanders",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "L"
                    ],
                    "last": "Monogue",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "Z"
                    ],
                    "last": "Jodlowski",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "B"
                    ],
                    "last": "Cutrell",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "JAMA",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF18": {
            "ref_id": "b18",
            "title": "Covid-19 , D\u00e9marrage de l'essai clinique Discovery",
            "authors": [],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF19": {
            "ref_id": "b19",
            "title": "Public health emergency SOLIDARITY trial of treatments for COVID-19 infection in hospitalized patients",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "M"
                    ],
                    "last": "Henao Restrepo",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Moorthy",
                    "suffix": ""
                },
                {
                    "first": "M-P",
                    "middle": [],
                    "last": "Preziosi",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF20": {
            "ref_id": "b20",
            "title": "Association between prenatal exposure to antiretroviral therapy and birth defects: an analysis of the French perinatal cohort study (ANRS CO1/CO11)",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Sibiude",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Mandelbrot",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Blanche",
                    "suffix": ""
                },
                {
                    "first": "Le",
                    "middle": [],
                    "last": "Chenadec",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Boullag-Bonnet",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": "Faye",
                    "middle": [
                        "A"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "PLoS Med",
            "volume": "11",
            "issn": "4",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF21": {
            "ref_id": "b21",
            "title": "Maternal and foetal outcomes among 4118 women with HIV infection treated with lopinavir/ritonavir during pregnancy: analysis of population-based surveillance data from the national study of HIV in pregnancy and childhood in the United Kingdom and Ireland",
            "authors": [
                {
                    "first": "P",
                    "middle": [
                        "A"
                    ],
                    "last": "Tookey",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Thorne",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Van Wyk",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Norton",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "BMC Infect Dis",
            "volume": "16",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF22": {
            "ref_id": "b22",
            "title": "Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro. Antiviral Res",
            "authors": [
                {
                    "first": "K-T",
                    "middle": [],
                    "last": "Choy",
                    "suffix": ""
                },
                {
                    "first": "Ay-L",
                    "middle": [],
                    "last": "Wong",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Kaewpreedee",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "F"
                    ],
                    "last": "Sia",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "Kpy",
                    "middle": [],
                    "last": "Hui",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "178",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF23": {
            "ref_id": "b23",
            "title": "Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Jeon",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Ko",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Choi",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "Y"
                    ],
                    "last": "Byun",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Park",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Internet]. Microbiology",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1101/2020.03.20.999730"
                ]
            }
        },
        "BIBREF24": {
            "ref_id": "b24",
            "title": "In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication [Internet]. Microbiology",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Touret",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Gilles",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Barral",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Nougair\u00e8de",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Decroly",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "De Lamballerie",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1101/2020.04.03.023846"
                ]
            }
        },
        "BIBREF25": {
            "ref_id": "b25",
            "title": "Zika virus cell tropism in the developing human brain and inhibition by azithromycin",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Retallack",
                    "suffix": ""
                },
                {
                    "first": "Di",
                    "middle": [],
                    "last": "Lullo",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Arias",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Knopp",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "A"
                    ],
                    "last": "Laurie",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "T"
                    ],
                    "last": "Sandoval-Espinosa",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Proc Natl Acad Sci",
            "volume": "113",
            "issn": "50",
            "pages": "14408--14421",
            "other_ids": {}
        },
        "BIBREF26": {
            "ref_id": "b26",
            "title": "Azithromycin Inhibits the Replication of Zika Virus",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Bosseboeuf",
                    "suffix": ""
                },
                {
                    "first": "Aubry",
                    "middle": [
                        "M"
                    ],
                    "last": "Nhan",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "De Pina",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "J"
                    ],
                    "last": "Rolain",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Raoult",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "J Antivir Antiretrovir",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF27": {
            "ref_id": "b27",
            "title": "Evaluation of Ebola Virus Inhibitors for Drug Repurposing",
            "authors": [
                {
                    "first": "P",
                    "middle": [
                        "B"
                    ],
                    "last": "Madrid",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "G"
                    ],
                    "last": "Panchal",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "K"
                    ],
                    "last": "Warren",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "C"
                    ],
                    "last": "Shurtleff",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "N"
                    ],
                    "last": "Endsley",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "E"
                    ],
                    "last": "Green",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "ACS Infect Dis",
            "volume": "1",
            "issn": "7",
            "pages": "317--343",
            "other_ids": {}
        },
        "BIBREF28": {
            "ref_id": "b28",
            "title": "Chloroquine and its metabolites in human cord blood, neonatal blood, and urine after maternal medication",
            "authors": [
                {
                    "first": "E",
                    "middle": [
                        "E"
                    ],
                    "last": "Essien",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "C"
                    ],
                    "last": "Afamefuna",
                    "suffix": ""
                }
            ],
            "year": 1982,
            "venue": "Clin Chem",
            "volume": "28",
            "issn": "5",
            "pages": "1148--52",
            "other_ids": {}
        },
        "BIBREF29": {
            "ref_id": "b29",
            "title": "Transfer of chloroquine and desethylchloroquine across the placenta and into milk in Melanesian mothers",
            "authors": [
                {
                    "first": "I",
                    "middle": [],
                    "last": "Law",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "F"
                    ],
                    "last": "Ilett",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "P"
                    ],
                    "last": "Hackett",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Page-Sharp",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Baiwog",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Gomorrai",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Br J Clin Pharmacol",
            "volume": "65",
            "issn": "5",
            "pages": "674--683",
            "other_ids": {}
        },
        "BIBREF30": {
            "ref_id": "b30",
            "title": "Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Mcgready",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "J"
                    ],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Wiladphaingern",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "A"
                    ],
                    "last": "Ashley",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "J"
                    ],
                    "last": "Rijken",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Boel",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Lancet Infect Dis",
            "volume": "12",
            "issn": "5",
            "pages": "388--96",
            "other_ids": {}
        },
        "BIBREF31": {
            "ref_id": "b31",
            "title": "Ocular toxicity in children exposed in utero to antimalarial drugs: review of the literature",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Osadchy",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Ratnapalan",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Koren",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "J Rheumatol",
            "volume": "38",
            "issn": "12",
            "pages": "2504--2512",
            "other_ids": {}
        },
        "BIBREF32": {
            "ref_id": "b32",
            "title": "In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)",
            "authors": [
                {
                    "first": "X",
                    "middle": [],
                    "last": "Yao",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Ye",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Cui",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Niu",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Clin Infect Dis Off Publ Infect Dis Soc Am",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF33": {
            "ref_id": "b33",
            "title": "Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Cao",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Hu",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Cell Discov",
            "volume": "6",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF34": {
            "ref_id": "b34",
            "title": "Combating COVID-19 with Chloroquine",
            "authors": [
                {
                    "first": "W",
                    "middle": [],
                    "last": "Hong",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Mol Cell Biol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF36": {
            "ref_id": "b36",
            "title": "Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial",
            "authors": [
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Hu",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Jiang",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Han",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Yan",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Epidemiology",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1101/2020.03.22.20040758"
                ]
            }
        },
        "BIBREF37": {
            "ref_id": "b37",
            "title": "Hydroxychloroquine in patients mainly with mild to moderate COVID-19: an open-label, randomized, controlled trial",
            "authors": [
                {
                    "first": "W",
                    "middle": [],
                    "last": "Tang",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Cao",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Han",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Sun",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1101/2020.04.10.20060558"
                ]
            }
        },
        "BIBREF38": {
            "ref_id": "b38",
            "title": "No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Molina",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Delaugerre",
                    "suffix": ""
                },
                {
                    "first": "Le",
                    "middle": [],
                    "last": "Goff",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": "Mela",
                    "middle": [
                        "-"
                    ],
                    "last": "Lima",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Ponscarme",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Goldwirt",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Med Mal Infect",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF39": {
            "ref_id": "b39",
            "title": "Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Geleris",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Sun",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Platt",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zucker",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Baldwin",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Hripcsak",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "N Engl J Med",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF40": {
            "ref_id": "b40",
            "title": "No evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for COVID-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Mahevas",
                    "suffix": ""
                },
                {
                    "first": "V-T",
                    "middle": [],
                    "last": "Tran",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Roumier",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Chabrol",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Paule",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Guillaud",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF42": {
            "ref_id": "b42",
            "title": "Hydroxychloroquine is associated with slower viral clearance in clinical COVID-19 patients with mild to moderate disease: A retrospective study",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Mallat",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Hamed",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Balkis",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "A"
                    ],
                    "last": "Mohamed",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Mooty",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Malik",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1101/2020.04.27.20082180"
                ]
            }
        },
        "BIBREF43": {
            "ref_id": "b43",
            "title": "Hydroxychloroquine application is associated with a decreased mortality in critically ill patients with COVID-19",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Yu",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "W"
                    ],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Emergency Medicine",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1101/2020.04.27.20073379"
                ]
            }
        },
        "BIBREF44": {
            "ref_id": "b44",
            "title": "Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. The Lancet",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "R"
                    ],
                    "last": "Mehra",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "S"
                    ],
                    "last": "Desai",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Ruschitzka",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "N"
                    ],
                    "last": "Patel",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF45": {
            "ref_id": "b45",
            "title": "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Million",
                    "suffix": ""
                },
                {
                    "first": "J-C",
                    "middle": [],
                    "last": "Lagier",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Gautret",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Colson",
                    "suffix": ""
                },
                {
                    "first": "P-E",
                    "middle": [],
                    "last": "Fournier",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Amrane",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Travel Med Infect Dis",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF46": {
            "ref_id": "b46",
            "title": "JORF n\u00b00012 du 15 janvier 2020. Texte n\u00b013. Arr\u00eat\u00e9 du 13 janvier 2020 portant classement sur les listes des substances v\u00e9n\u00e9neuses.rtf",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF47": {
            "ref_id": "b47",
            "title": "Hydroxychloroquine retinopathyimplications of research advances for rheumatology care",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Jorge",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Ung",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "H"
                    ],
                    "last": "Young",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "B"
                    ],
                    "last": "Melles",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "K"
                    ],
                    "last": "Choi",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Nat Rev Rheumatol",
            "volume": "14",
            "issn": "12",
            "pages": "693--703",
            "other_ids": {}
        },
        "BIBREF48": {
            "ref_id": "b48",
            "title": "Hydroxychloroquine-induced Retinal Toxicity",
            "authors": [
                {
                    "first": "K",
                    "middle": [
                        "L"
                    ],
                    "last": "Carter",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "V"
                    ],
                    "last": "Do",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Rheumatol",
            "volume": "47",
            "issn": "4",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF49": {
            "ref_id": "b49",
            "title": "Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Chatre",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Roubille",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Vernhet",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Jorgensen",
                    "suffix": ""
                },
                {
                    "first": "Y-M",
                    "middle": [],
                    "last": "Pers",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Drug Saf",
            "volume": "41",
            "issn": "10",
            "pages": "919--950",
            "other_ids": {}
        },
        "BIBREF50": {
            "ref_id": "b50",
            "title": "Evidence of transplacental passage of hydroxychloroquine in humans",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Costedoat-Chalumeau",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Amoura",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Aymard",
                    "suffix": ""
                },
                {
                    "first": "Thd",
                    "middle": [],
                    "last": "Le",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Wechsler",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Vauthier",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Arthritis Rheum",
            "volume": "46",
            "issn": "4",
            "pages": "1123--1127",
            "other_ids": {}
        },
        "BIBREF51": {
            "ref_id": "b51",
            "title": "Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Costedoat-Chalumeau",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Amoura",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Duhaut",
                    "suffix": ""
                },
                {
                    "first": "Dlt",
                    "middle": [],
                    "last": "Huong",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Sebbough",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Wechsler",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Arthritis Rheum",
            "volume": "48",
            "issn": "11",
            "pages": "3207--3218",
            "other_ids": {}
        },
        "BIBREF52": {
            "ref_id": "b52",
            "title": "Disease-modifying antirheumatic drugs in pregnancy: current status and implications for the future",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Vroom",
                    "suffix": ""
                },
                {
                    "first": "Hek",
                    "middle": [],
                    "last": "De Walle",
                    "suffix": ""
                },
                {
                    "first": "Majf",
                    "middle": [],
                    "last": "Van De Laar",
                    "suffix": ""
                },
                {
                    "first": "Jrbj",
                    "middle": [],
                    "last": "Brouwers",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "De Jong-Van Den",
                    "suffix": ""
                },
                {
                    "first": "Ltw",
                    "middle": [],
                    "last": "Berg",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Drug Saf",
            "volume": "29",
            "issn": "10",
            "pages": "845--63",
            "other_ids": {}
        },
        "BIBREF53": {
            "ref_id": "b53",
            "title": "Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Abarientos",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Sperber",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "L"
                    ],
                    "last": "Shapiro",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "S"
                    ],
                    "last": "Aronow",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "P"
                    ],
                    "last": "Chao",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "Y"
                    ],
                    "last": "Ash",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Expert Opin Drug Saf",
            "volume": "10",
            "issn": "5",
            "pages": "705--719",
            "other_ids": {}
        },
        "BIBREF54": {
            "ref_id": "b54",
            "title": "Electroretinograms of children born to mothers treated with hydroxychloroquine during pregnancy and breast-feeding: comment on the article by Costedoat-Chalumeau et al. Arthritis Rheum",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Cimaz",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Brucato",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Meregalli",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Muscar\u00e1",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Sergi",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "",
            "volume": "50",
            "issn": "",
            "pages": "3057--3058",
            "other_ids": {}
        },
        "BIBREF55": {
            "ref_id": "b55",
            "title": "A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus-A possible reference for coronavirus disease-19 treatment option",
            "authors": [
                {
                    "first": "T-T",
                    "middle": [],
                    "last": "Yao",
                    "suffix": ""
                },
                {
                    "first": "J-D",
                    "middle": [],
                    "last": "Qian",
                    "suffix": ""
                },
                {
                    "first": "W-Y",
                    "middle": [],
                    "last": "Zhu",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "G-Q",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Med Virol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF56": {
            "ref_id": "b56",
            "title": "Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV",
            "authors": [
                {
                    "first": "T",
                    "middle": [
                        "P"
                    ],
                    "last": "Sheahan",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "C"
                    ],
                    "last": "Sims",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "R"
                    ],
                    "last": "Leist",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Sch\u00e4fer",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Won",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "J"
                    ],
                    "last": "Brown",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Nat Commun",
            "volume": "11",
            "issn": "1",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF57": {
            "ref_id": "b57",
            "title": "A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Cao",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Wen",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Fan",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "N Engl J Med",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF58": {
            "ref_id": "b58",
            "title": "Prise en charge m\u00e9dicale des personnes vivants avec le VIH. Recommandations du groupe d'experts. D\u00e9sir d'enfant et grossesse (mai 2018)",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Blanc",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Bonnet",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Brun-Vezinet",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Costagliola",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Dabis",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Delobel",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF59": {
            "ref_id": "b59",
            "title": "European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) Study Group. Nucleoside reverse transcriptase inhibitor backbones and pregnancy outcomes",
            "authors": [],
            "year": 2019,
            "venue": "AIDS Lond Engl",
            "volume": "33",
            "issn": "2",
            "pages": "295--304",
            "other_ids": {}
        },
        "BIBREF60": {
            "ref_id": "b60",
            "title": "Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Tubiana",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Mandelbrot",
                    "suffix": ""
                },
                {
                    "first": "Le",
                    "middle": [],
                    "last": "Chenadec",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Delmas",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Rouzioux",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Hirt",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Clin Infect Dis Off Publ Infect Dis Soc Am",
            "volume": "57",
            "issn": "6",
            "pages": "891--902",
            "other_ids": {}
        },
        "BIBREF61": {
            "ref_id": "b61",
            "title": "Population approach to analyze the pharmacokinetics of free and total lopinavir in HIV-infected pregnant women and consequences for dose adjustment",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Fauchet",
                    "suffix": ""
                },
                {
                    "first": "J-M",
                    "middle": [],
                    "last": "Treluyer",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "M"
                    ],
                    "last": "Illamola",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Pressiat",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Lui",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Valade",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Antimicrob Agents Chemother",
            "volume": "59",
            "issn": "9",
            "pages": "5727--5762",
            "other_ids": {}
        },
        "BIBREF62": {
            "ref_id": "b62",
            "title": "Placental transfer of lopinavir/ritonavir in the ex vivo human cotyledon perfusion model",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Gavard",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Gil",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Peytavin",
                    "suffix": ""
                },
                {
                    "first": "P-F",
                    "middle": [],
                    "last": "Ceccaldi",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Ferreira",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Farinotti",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Am J Obstet Gynecol",
            "volume": "195",
            "issn": "1",
            "pages": "296--301",
            "other_ids": {}
        },
        "BIBREF63": {
            "ref_id": "b63",
            "title": "Transplacental transfer of antiretroviral drugs and newborn birth weight in HIV-infected pregnant women",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Ivanovic",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Nicastri",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "M"
                    ],
                    "last": "Anceschi",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Ascenzi",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Signore",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Pisani",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Curr HIV Res",
            "volume": "7",
            "issn": "6",
            "pages": "620--625",
            "other_ids": {}
        },
        "BIBREF64": {
            "ref_id": "b64",
            "title": "Transplacental passage of protease inhibitors at delivery",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Marzolini",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Rudin",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "A"
                    ],
                    "last": "Decosterd",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Telenti",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Schreyer",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Biollaz",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "AIDS Lond Engl",
            "volume": "16",
            "issn": "6",
            "pages": "889--93",
            "other_ids": {}
        },
        "BIBREF65": {
            "ref_id": "b65",
            "title": "Reduced indinavir exposure during pregnancy",
            "authors": [
                {
                    "first": "T",
                    "middle": [
                        "R"
                    ],
                    "last": "Cressey",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "M"
                    ],
                    "last": "Best",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Achalapong",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Stek",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Chotivanich",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Br J Clin Pharmacol",
            "volume": "76",
            "issn": "3",
            "pages": "475--83",
            "other_ids": {}
        },
        "BIBREF66": {
            "ref_id": "b66",
            "title": "Functional role of p-glycoprotein and binding protein effect on the placental transfer of lopinavir/ritonavir in the ex vivo human perfusion model",
            "authors": [
                {
                    "first": "P-F",
                    "middle": [],
                    "last": "Ceccaldi",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Gavard",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Mandelbrot",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Rey",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Farinotti",
                    "suffix": ""
                },
                {
                    "first": "J-M",
                    "middle": [],
                    "last": "Treluyer",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Obstet Gynecol Int",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF67": {
            "ref_id": "b67",
            "title": "Placental transfer of darunavir in an ex vivo human cotyledon perfusion model",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Mandelbrot",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Duro",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Belissa",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Peytavin",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Antimicrob Agents Chemother",
            "volume": "58",
            "issn": "9",
            "pages": "5617--5637",
            "other_ids": {}
        },
        "BIBREF68": {
            "ref_id": "b68",
            "title": "Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "G"
                    ],
                    "last": "Fowler",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Qin",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "A"
                    ],
                    "last": "Fiscus",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "S"
                    ],
                    "last": "Currier",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "M"
                    ],
                    "last": "Flynn",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Chipato",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "N Engl J Med",
            "volume": "375",
            "issn": "18",
            "pages": "1726--1763",
            "other_ids": {}
        },
        "BIBREF69": {
            "ref_id": "b69",
            "title": "Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy",
            "authors": [
                {
                    "first": "K",
                    "middle": [
                        "M"
                    ],
                    "last": "Powis",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Kitch",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Ogwu",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "D"
                    ],
                    "last": "Hughes",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Lockman",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Leidner",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "J Infect Dis",
            "volume": "204",
            "issn": "4",
            "pages": "506--520",
            "other_ids": {}
        },
        "BIBREF70": {
            "ref_id": "b70",
            "title": "Association of prenatal and postnatal exposure to lopinavir-ritonavir and adrenal dysfunction among uninfected infants of HIV-infected mothers",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Simon",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Warszawski",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Kariyawasam",
                    "suffix": ""
                },
                {
                    "first": "Le",
                    "middle": [],
                    "last": "Chenadec",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Benhammou",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Czernichow",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "JAMA",
            "volume": "306",
            "issn": "1",
            "pages": "70--78",
            "other_ids": {}
        },
        "BIBREF71": {
            "ref_id": "b71",
            "title": "Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir",
            "authors": [
                {
                    "first": "E",
                    "middle": [
                        "P"
                    ],
                    "last": "Tchesnokov",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "Y"
                    ],
                    "last": "Feng",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "P"
                    ],
                    "last": "Porter",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "G\u00f6tte",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Viruses",
            "volume": "11",
            "issn": "4",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF72": {
            "ref_id": "b72",
            "title": "Controlled Trial of Ebola Virus Disease Therapeutics",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Mulangu",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "E"
                    ],
                    "last": "Dodd",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "T"
                    ],
                    "last": "Davey",
                    "suffix": ""
                },
                {
                    "first": "Tshiani",
                    "middle": [],
                    "last": "Mbaya",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Proschan",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Mukadi",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "N Engl J Med",
            "volume": "12",
            "issn": "24",
            "pages": "2293--303",
            "other_ids": {}
        },
        "BIBREF73": {
            "ref_id": "b73",
            "title": "Broadspectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses",
            "authors": [
                {
                    "first": "T",
                    "middle": [
                        "P"
                    ],
                    "last": "Sheahan",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "C"
                    ],
                    "last": "Sims",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "L"
                    ],
                    "last": "Graham",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [
                        "D"
                    ],
                    "last": "Menachery",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "E"
                    ],
                    "last": "Gralinski",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "B"
                    ],
                    "last": "Case",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Sci Transl Med",
            "volume": "9",
            "issn": "396",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF74": {
            "ref_id": "b74",
            "title": "Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "J"
                    ],
                    "last": "Brown",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "J"
                    ],
                    "last": "Won",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "L"
                    ],
                    "last": "Graham",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "H"
                    ],
                    "last": "Dinnon",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "C"
                    ],
                    "last": "Sims",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "Y"
                    ],
                    "last": "Feng",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Antiviral Res",
            "volume": "169",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF75": {
            "ref_id": "b75",
            "title": "Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "De Wit",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Feldmann",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Cronin",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Jordan",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Okumura",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Thomas",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Proc Natl Acad Sci",
            "volume": "117",
            "issn": "12",
            "pages": "6771--6777",
            "other_ids": {}
        },
        "BIBREF76": {
            "ref_id": "b76",
            "title": "The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "J"
                    ],
                    "last": "Gordon",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "P"
                    ],
                    "last": "Tchesnokov",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "Y"
                    ],
                    "last": "Feng",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "P"
                    ],
                    "last": "Porter",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Gotte",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Biol Chem",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF77": {
            "ref_id": "b77",
            "title": "Remdesivir for the Treatment of Covid-19 -Preliminary Report",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "H"
                    ],
                    "last": "Beigel",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "M"
                    ],
                    "last": "Tomashek",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "E"
                    ],
                    "last": "Dodd",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "K"
                    ],
                    "last": "Mehta",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "S"
                    ],
                    "last": "Zingman",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "C"
                    ],
                    "last": "Kalil",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "N Engl J Med",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF78": {
            "ref_id": "b78",
            "title": "Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. The Lancet",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Du",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Du",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Jin",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "395",
            "issn": "",
            "pages": "1569--78",
            "other_ids": {}
        },
        "BIBREF79": {
            "ref_id": "b79",
            "title": "Compassionate Use of Remdesivir for Patients with Severe Covid-19",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Grein",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Ohmagari",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Shin",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Diaz",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Asperges",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Castagna",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "N Engl J Med",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF80": {
            "ref_id": "b80",
            "title": "Assessment report on Medicinal products under development for the treatment of Ebola",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Ema/",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF81": {
            "ref_id": "b81",
            "title": "Avis relatif \u00e0 la prise en charge des cas confirm\u00e9s d'infection au virus SARS-CoV-2",
            "authors": [],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF82": {
            "ref_id": "b82",
            "title": "Avis relatif \u00e0 la prise en charge des cas confirm\u00e9s d'infection au virus SARS-CoV-2",
            "authors": [],
            "year": 2020,
            "venue": "",
            "volume": "33",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF83": {
            "ref_id": "b83",
            "title": "Epidemiology, Pathogenesis, and Control of COVID-19",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Jin",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "Ji",
                    "middle": [
                        "W"
                    ],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Viruses",
            "volume": "12",
            "issn": "4",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF84": {
            "ref_id": "b84",
            "title": "Lack of Antiviral Activity of Darunavir against SARS-CoV-2 [Internet]. Infectious Diseases (except HIV/AIDS)",
            "authors": [
                {
                    "first": "De",
                    "middle": [],
                    "last": "Meyer",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Bojkova",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Cinati",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Van Damme",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Buyck",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Van Loock",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1101/2020.04.03.20052548"
                ]
            }
        },
        "BIBREF85": {
            "ref_id": "b85",
            "title": "Transplacental transfer of oseltamivir phosphate and its metabolite oseltamivir carboxylate using the ex vivo human placenta perfusion model in Chinese Hans population",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Duan",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Yao",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Zheng",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "J Matern-Fetal Neonatal Med Off J Eur Assoc Perinat Med Fed Asia Ocean Perinat Soc Int Soc Perinat Obstet",
            "volume": "30",
            "issn": "11",
            "pages": "1288--92",
            "other_ids": {}
        },
        "BIBREF86": {
            "ref_id": "b86",
            "title": "Oseltamivir use in pregnancy: Risk of birth defects, preterm delivery, and small for gestational age infants",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "D"
                    ],
                    "last": "Chambers",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Johnson",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Luo",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "L"
                    ],
                    "last": "Jones",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Otis Collaborative Research",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Group",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Birth Defects Res",
            "volume": "111",
            "issn": "19",
            "pages": "1487--93",
            "other_ids": {}
        },
        "BIBREF87": {
            "ref_id": "b87",
            "title": "Efficacy of favipiravir (T-705) in nonhuman primates infected with Ebola virus or Marburg virus",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "L"
                    ],
                    "last": "Bixler",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "M"
                    ],
                    "last": "Bocan",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Wells",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "S"
                    ],
                    "last": "Wetzel",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "A"
                    ],
                    "last": "Van Tongeren",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Dong",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Antiviral Res",
            "volume": "151",
            "issn": "",
            "pages": "97--104",
            "other_ids": {}
        },
        "BIBREF88": {
            "ref_id": "b88",
            "title": "Favipiravir as a potential countermeasure against neglected and emerging RNA viruses",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Delang",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Abdelnabi",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Neyts",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Antiviral Res",
            "volume": "153",
            "issn": "",
            "pages": "85--94",
            "other_ids": {}
        },
        "BIBREF89": {
            "ref_id": "b89",
            "title": "Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Furuta",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Komeno",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Nakamura",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Proc Jpn Acad Ser B Phys Biol Sci",
            "volume": "93",
            "issn": "7",
            "pages": "449--63",
            "other_ids": {}
        },
        "BIBREF90": {
            "ref_id": "b90",
            "title": "Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Oestereich",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "L\u00fcdtke",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Wurr",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Rieger",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Mu\u00f1oz-Fontela",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "G\u00fcnther",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Antiviral Res",
            "volume": "105",
            "issn": "",
            "pages": "17--21",
            "other_ids": {}
        },
        "BIBREF91": {
            "ref_id": "b91",
            "title": "Laboratory Findings, Compassionate Use of Favipiravir, and Outcome in Patients With Ebola Virus Disease, Guinea, 2015-A Retrospective Observational Study",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Kerber",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Lorenz",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Duraffour",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Sissoko",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Rudolf",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Jaeger",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "J Infect Dis",
            "volume": "220",
            "issn": "2",
            "pages": "195--202",
            "other_ids": {}
        },
        "BIBREF92": {
            "ref_id": "b92",
            "title": "Combination Therapy with Oseltamivir and Favipiravir Delays Mortality but Does Not Prevent Oseltamivir Resistance in Immunodeficient Mice Infected with Pandemic A(H1N1) Influenza Virus. Viruses",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Baz",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Carbonneau",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Rh\u00e9aume",
                    "suffix": ""
                },
                {
                    "first": "M-H",
                    "middle": [],
                    "last": "Cavanagh",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Boivin",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "",
            "volume": "10",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF93": {
            "ref_id": "b93",
            "title": "Comparative effectiveness of combined favipiravir and oseltamivir therapy versus oseltamivir monotherapy in critically ill patients with influenza virus infection",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Fan",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Salam",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Horby",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "G"
                    ],
                    "last": "Hayden",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "J Infect Dis",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF94": {
            "ref_id": "b94",
            "title": "Influenza virus polymerase inhibitors in clinical development",
            "authors": [
                {
                    "first": "F",
                    "middle": [
                        "G"
                    ],
                    "last": "Hayden",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Shindo",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Curr Opin Infect Dis",
            "volume": "32",
            "issn": "2",
            "pages": "176--86",
            "other_ids": {}
        },
        "BIBREF95": {
            "ref_id": "b95",
            "title": "Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "S"
                    ],
                    "last": "Omrani",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "M"
                    ],
                    "last": "Saad",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Baig",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Bahloul",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Abdul-Matin",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "Y"
                    ],
                    "last": "Alaidaroos",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "Lancet Infect Dis",
            "volume": "14",
            "issn": "11",
            "pages": "1090--1095",
            "other_ids": {}
        },
        "BIBREF96": {
            "ref_id": "b96",
            "title": "Ribavirin and Interferon Therapy for Critically Ill Patients With Middle East Respiratory Syndrome: A Multicenter Observational Study",
            "authors": [
                {
                    "first": "Y",
                    "middle": [
                        "M"
                    ],
                    "last": "Arabi",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Shalhoub",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Mandourah",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Al-Hameed",
                    "suffix": ""
                },
                {
                    "first": "Al-Omari",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": "Al",
                    "middle": [],
                    "last": "Qasim",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Clin Infect Dis Off Publ Infect Dis Soc Am",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF97": {
            "ref_id": "b97",
            "title": "The Ribavirin Pregnancy Registry: Findings after 5 years of enrollment",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "S"
                    ],
                    "last": "Roberts",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "K"
                    ],
                    "last": "Miller",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "K"
                    ],
                    "last": "Jones",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "L"
                    ],
                    "last": "Lindsay",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "F"
                    ],
                    "last": "Greene",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "C"
                    ],
                    "last": "Maddrey",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Birt Defects Res A Clin Mol Teratol",
            "volume": "88",
            "issn": "7",
            "pages": "551--560",
            "other_ids": {}
        },
        "BIBREF98": {
            "ref_id": "b98",
            "title": "Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost?",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Sibiude",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Warszawski",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Tubiana",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Dollfus",
                    "suffix": ""
                },
                {
                    "first": "Faye",
                    "middle": [
                        "A"
                    ],
                    "last": "Rouzioux",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "",
            "volume": "54",
            "issn": "",
            "pages": "1348--60",
            "other_ids": {}
        },
        "BIBREF99": {
            "ref_id": "b99",
            "title": "HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Yamamoto",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Yoshinaka",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Amari",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Nakano",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Cinatl",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Biochem Biophys Res Commun",
            "volume": "318",
            "issn": "3",
            "pages": "719--744",
            "other_ids": {}
        },
        "BIBREF102": {
            "ref_id": "b102",
            "title": "Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Deng",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Zeng",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Infect",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF103": {
            "ref_id": "b103",
            "title": "Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Lian",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Xie",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Lin",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Lin",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF104": {
            "ref_id": "b104",
            "title": "Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Yu",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Kang",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Xiong",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Lin",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet Infect Dis",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF105": {
            "ref_id": "b105",
            "title": "Pharmacokinetics of ivermectin after maternal or fetal intravenous administration in sheep",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "P\u00e9rez",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Palma",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "J"
                    ],
                    "last": "N\u00fa\u00f1ez",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Cox",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "J Vet Pharmacol Ther",
            "volume": "31",
            "issn": "5",
            "pages": "406--420",
            "other_ids": {}
        },
        "BIBREF106": {
            "ref_id": "b106",
            "title": "Safety of oral ivermectin during pregnancy: a systematic review and meta-analysis. Lancet Glob Health",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Nicolas",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "F"
                    ],
                    "last": "Maia",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Bassat",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "C"
                    ],
                    "last": "Kobylinski",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Monteiro",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "R"
                    ],
                    "last": "Rabinovich",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "8",
            "issn": "",
            "pages": "92--100",
            "other_ids": {}
        },
        "BIBREF107": {
            "ref_id": "b107",
            "title": "Highlights of prescribing information, FDA.pdf",
            "authors": [],
            "year": null,
            "venue": "AVONEX",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF108": {
            "ref_id": "b108",
            "title": "Final results from the Betaseron (interferon \u03b2-1b) Pregnancy Registry: a prospective observational study of birth defects and pregnancy-related adverse events",
            "authors": [
                {
                    "first": "P",
                    "middle": [
                        "K"
                    ],
                    "last": "Coyle",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "M"
                    ],
                    "last": "Sinclair",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "E"
                    ],
                    "last": "Scheuerle",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Thorp",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "D"
                    ],
                    "last": "Albano",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "J"
                    ],
                    "last": "Rametta",
                    "suffix": ""
                }
            ],
            "year": 2014,
            "venue": "BMJ Open",
            "volume": "4",
            "issn": "5",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF109": {
            "ref_id": "b109",
            "title": "Pregnancy outcomes in interferon-beta-exposed patients with multiple sclerosis: results from the European Interferon-beta Pregnancy Registry",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Hellwig",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Geissbuehler",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Sabid\u00f3",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Popescu",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Adamo",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Klinger",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Neurol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF110": {
            "ref_id": "b110",
            "title": "Pregnancy outcomes from the global pharmacovigilance database on interferon beta-1b exposure",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Hellwig",
                    "suffix": ""
                },
                {
                    "first": "Duarte",
                    "middle": [],
                    "last": "Caron",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Wicklein",
                    "suffix": ""
                },
                {
                    "first": "E-M",
                    "middle": [],
                    "last": "Bhatti",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Adamo",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Ther Adv Neurol Disord",
            "volume": "13",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF111": {
            "ref_id": "b111",
            "title": "Experimental study of transplacental passage of alpha interferon by two assay techniques",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Waysbort",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Giroux",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Mansat",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Teixeira",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "C"
                    ],
                    "last": "Dumas",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Puel",
                    "suffix": ""
                }
            ],
            "year": 1993,
            "venue": "Antimicrob Agents Chemother",
            "volume": "37",
            "issn": "6",
            "pages": "1232--1239",
            "other_ids": {}
        },
        "BIBREF114": {
            "ref_id": "b114",
            "title": "Pharmacokinetics of interferon-alpha in pregnant women and fetoplacental passage",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "C"
                    ],
                    "last": "Pons",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Lebon",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Frydman",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "F"
                    ],
                    "last": "Delfraissy",
                    "suffix": ""
                }
            ],
            "year": 1995,
            "venue": "Fetal Diagn Ther",
            "volume": "10",
            "issn": "1",
            "pages": "7--10",
            "other_ids": {}
        },
        "BIBREF115": {
            "ref_id": "b115",
            "title": "Pivotal Role of Convalescent Plasma in Managing Emerging Infectious Diseases. Vox Sang",
            "authors": [
                {
                    "first": "H",
                    "middle": [
                        "K"
                    ],
                    "last": "Wong",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "K"
                    ],
                    "last": "Lee",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF116": {
            "ref_id": "b116",
            "title": "Convalescent plasma: new evidence for an old therapeutic tool? Blood Transfus Trasfus Sangue",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Marano",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Vaglio",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Pupella",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Facco",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Catalano",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "M"
                    ],
                    "last": "Liumbruno",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "",
            "volume": "14",
            "issn": "",
            "pages": "152--159",
            "other_ids": {}
        },
        "BIBREF117": {
            "ref_id": "b117",
            "title": "Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Van Griensven",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Edwards",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "De Lamballerie",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "G"
                    ],
                    "last": "Semple",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Gallian",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Baize",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "N Engl J Med",
            "volume": "374",
            "issn": "1",
            "pages": "33--42",
            "other_ids": {}
        },
        "BIBREF118": {
            "ref_id": "b118",
            "title": "Use of convalescent plasma therapy in SARS patients in Hong Kong",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Cheng",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Wong",
                    "suffix": ""
                },
                {
                    "first": "Yoy",
                    "middle": [],
                    "last": "Soo",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "S"
                    ],
                    "last": "Wong",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "K"
                    ],
                    "last": "Lee",
                    "suffix": ""
                },
                {
                    "first": "Mhl",
                    "middle": [],
                    "last": "Ng",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Eur J Clin Microbiol Infect Dis Off Publ Eur Soc Clin Microbiol",
            "volume": "24",
            "issn": "1",
            "pages": "44--50",
            "other_ids": {}
        },
        "BIBREF119": {
            "ref_id": "b119",
            "title": "Treatment with convalescent plasma for critically ill patients with SARS-CoV-2 infection",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Tan",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Dong",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Chest",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF120": {
            "ref_id": "b120",
            "title": "Placental transport of immunoglobulin G. Vaccine",
            "authors": [
                {
                    "first": "N",
                    "middle": [
                        "E"
                    ],
                    "last": "Simister",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "",
            "volume": "21",
            "issn": "",
            "pages": "3365--3374",
            "other_ids": {}
        },
        "BIBREF121": {
            "ref_id": "b121",
            "title": "Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Channappanavar",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Perlman",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Semin Immunopathol",
            "volume": "39",
            "issn": "5",
            "pages": "529--568",
            "other_ids": {}
        },
        "BIBREF122": {
            "ref_id": "b122",
            "title": "Placental transfer of tocilizumab in a patient with rheumatoid arthritis",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Tada",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Sakai",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Nakao",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Maruyama",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Ono",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Koarada",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Rheumatol Oxf Engl",
            "volume": "58",
            "issn": "9",
            "pages": "1694--1699",
            "other_ids": {}
        },
        "BIBREF123": {
            "ref_id": "b123",
            "title": "Tocilizumab concentrations in maternal serum and breast milk during breastfeeding and a safety assessment in infants: a case study",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Saito",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Yakuwa",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Takai",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Nakajima",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Kaneko",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Goto",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Rheumatology",
            "volume": "57",
            "issn": "8",
            "pages": "1499--501",
            "other_ids": {}
        },
        "BIBREF124": {
            "ref_id": "b124",
            "title": "Pregnancy outcomes after exposure to tocilizumab: A retrospective analysis of 61 patients in Japan",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Nakajima",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Watanabe",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Mochizuki",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Nakasone",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Ishizuka",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Murashima",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Mod Rheumatol",
            "volume": "26",
            "issn": "5",
            "pages": "667--71",
            "other_ids": {}
        },
        "BIBREF125": {
            "ref_id": "b125",
            "title": "Tocilizumab use in pregnancy: Analysis of a global safety database including data from clinical trials and post-marketing data",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Hoeltzenbein",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Beck",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Rajwanshi",
                    "suffix": ""
                },
                {
                    "first": "G\u00f8testam",
                    "middle": [],
                    "last": "Skorpen",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Berber",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Schaefer",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Semin Arthritis Rheum",
            "volume": "46",
            "issn": "2",
            "pages": "238--283",
            "other_ids": {}
        },
        "BIBREF126": {
            "ref_id": "b126",
            "title": "The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "G\u00f6testam Skorpen",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Hoeltzenbein",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Tincani",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Fischer-Betz",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Elefant",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Chambers",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Ann Rheum Dis",
            "volume": "75",
            "issn": "5",
            "pages": "795--810",
            "other_ids": {}
        },
        "BIBREF127": {
            "ref_id": "b127",
            "title": "International multi-centre study of pregnancy outcomes with interleukin-1 inhibitors. Rheumatol Oxf Engl",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Youngstein",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Hoffmann",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "G\u00fcl",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Lane",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Williams",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "M"
                    ],
                    "last": "Rowczenio",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "",
            "volume": "56",
            "issn": "",
            "pages": "2102--2110",
            "other_ids": {}
        },
        "BIBREF128": {
            "ref_id": "b128",
            "title": "Benefit-Risk Profile of Sphingosine-1-Phosphate Receptor Modulators in Relapsing and Secondary Progressive Multiple Sclerosis",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Comi",
                    "suffix": ""
                },
                {
                    "first": "H-P",
                    "middle": [],
                    "last": "Hartung",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Bakshi",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [
                        "M"
                    ],
                    "last": "Williams",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Wiendl",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Drugs",
            "volume": "77",
            "issn": "16",
            "pages": "1755--68",
            "other_ids": {}
        },
        "BIBREF129": {
            "ref_id": "b129",
            "title": "Long-term efficacy and safety of fingolimod in Japanese patients with relapsing multiple sclerosis: 3-year results of the phase 2 extension study",
            "authors": [
                {
                    "first": "T",
                    "middle": [],
                    "last": "Saida",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Itoyama",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Kikuchi",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Hao",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Kurosawa",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Ueda",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "BMC Neurol",
            "volume": "17",
            "issn": "1",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF130": {
            "ref_id": "b130",
            "title": "Evaluation of pregnancy outcomes in patients with multiple sclerosis after fingolimod exposure",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Geissb\u00fchler",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Vile",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Koren",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Guennec",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Butzkueven",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Tilson",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Ther Adv Neurol Disord",
            "volume": "11",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF131": {
            "ref_id": "b131",
            "title": "Baricitinib: A Review in Rheumatoid Arthritis",
            "authors": [
                {
                    "first": "Z",
                    "middle": [
                        "T"
                    ],
                    "last": "Al-Salama",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "J"
                    ],
                    "last": "Scott",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Drugs",
            "volume": "78",
            "issn": "7",
            "pages": "761--72",
            "other_ids": {}
        },
        "BIBREF132": {
            "ref_id": "b132",
            "title": "Baricitinib exposure during pregnancy in rheumatoid arthritis",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Costanzo",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Firinu",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Losa",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Deidda",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "P"
                    ],
                    "last": "Barca",
                    "suffix": ""
                },
                {
                    "first": "Del",
                    "middle": [],
                    "last": "Giacco",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Ther Adv Musculoskelet Dis",
            "volume": "12",
            "issn": "",
            "pages": "1759720--19899296",
            "other_ids": {}
        },
        "BIBREF133": {
            "ref_id": "b133",
            "title": "The use of biologics and small molecules in pregnant patients with rheumatic diseases",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Gerosa",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "M"
                    ],
                    "last": "Argolini",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Artusi",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "B"
                    ],
                    "last": "Chighizola",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Expert Rev Clin Pharmacol",
            "volume": "11",
            "issn": "10",
            "pages": "987--98",
            "other_ids": {}
        },
        "BIBREF134": {
            "ref_id": "b134",
            "title": "Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease",
            "authors": [
                {
                    "first": "U",
                    "middle": [],
                    "last": "Mahadevan",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Kane",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "J"
                    ],
                    "last": "Sandborn",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "D"
                    ],
                    "last": "Cohen",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Hanson",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "P"
                    ],
                    "last": "Terdiman",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Aliment Pharmacol Ther",
            "volume": "21",
            "issn": "6",
            "pages": "733--741",
            "other_ids": {}
        },
        "BIBREF135": {
            "ref_id": "b135",
            "title": "Case report: evidence for transplacental transfer of maternally administered infliximab to the newborn",
            "authors": [
                {
                    "first": "E",
                    "middle": [
                        "A"
                    ],
                    "last": "Vasiliauskas",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "A"
                    ],
                    "last": "Church",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Silverman",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Barry",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "R"
                    ],
                    "last": "Targan",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "C"
                    ],
                    "last": "Dubinsky",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc",
            "volume": "4",
            "issn": "10",
            "pages": "1255--1263",
            "other_ids": {}
        },
        "BIBREF136": {
            "ref_id": "b136",
            "title": "Therapeutic infliximab drug level in a child born to a woman with ulcerative colitis treated until gestation week 31",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Steenholdt",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Al-Khalaf",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "A"
                    ],
                    "last": "Ainsworth",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Brynskov",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "J Crohns Colitis",
            "volume": "6",
            "issn": "3",
            "pages": "358--61",
            "other_ids": {}
        },
        "BIBREF137": {
            "ref_id": "b137",
            "title": "Colchicine may not be effective in COVID-19 infection; it may even be harmful?",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Cumhur Cure",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Kucuk",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Cure",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Clin Rheumatol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF138": {
            "ref_id": "b138",
            "title": "Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis",
            "authors": [
                {
                    "first": "O",
                    "middle": [],
                    "last": "Gendelman",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Amital",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "L"
                    ],
                    "last": "Bragazzi",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Watad",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Chodick",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Autoimmun Rev",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF139": {
            "ref_id": "b139",
            "title": "The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "G"
                    ],
                    "last": "Deftereos",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Siasos",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Giannopoulos",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "A"
                    ],
                    "last": "Vrachatis",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Angelidis",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "G"
                    ],
                    "last": "Giotaki",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Hell J Cardiol HJC Hell Kardiologike Epitheorese",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF140": {
            "ref_id": "b140",
            "title": "Transplacental passage of colchicine in familial Mediterranean fever",
            "authors": [
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Amoura",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Schermann",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Wechsler",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Zerah",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Goodeau",
                    "suffix": ""
                }
            ],
            "year": 1994,
            "venue": "J Rheumatol",
            "volume": "21",
            "issn": "2",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF141": {
            "ref_id": "b141",
            "title": "Use of colchicine in pregnancy: a systematic review and meta-analysis",
            "authors": [
                {
                    "first": "P",
                    "middle": [
                        "L"
                    ],
                    "last": "Indraratna",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Virk",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Gurram",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "O"
                    ],
                    "last": "Day",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Rheumatol Oxf Engl",
            "volume": "57",
            "issn": "2",
            "pages": "382--389",
            "other_ids": {}
        },
        "BIBREF142": {
            "ref_id": "b142",
            "title": "Pregnancy outcome after in utero exposure to colchicine",
            "authors": [
                {
                    "first": "O",
                    "middle": [],
                    "last": "Diav-Citrin",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Shechtman",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Schwartz",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Avgil-Tsadok",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Finkel-Pekarsky",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Wajnberg",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Am J Obstet Gynecol",
            "volume": "203",
            "issn": "2",
            "pages": "144--145",
            "other_ids": {}
        },
        "BIBREF143": {
            "ref_id": "b143",
            "title": "The placental transfer of betamethasone",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "C"
                    ],
                    "last": "Petersen",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "L"
                    ],
                    "last": "Nation",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "J"
                    ],
                    "last": "Ashley",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "G"
                    ],
                    "last": "Mcbride",
                    "suffix": ""
                }
            ],
            "year": 1980,
            "venue": "Eur J Clin Pharmacol",
            "volume": "18",
            "issn": "3",
            "pages": "245--252",
            "other_ids": {}
        },
        "BIBREF144": {
            "ref_id": "b144",
            "title": "Drug therapy of the fetus",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "M"
                    ],
                    "last": "Ward",
                    "suffix": ""
                }
            ],
            "year": 1993,
            "venue": "J Clin Pharmacol",
            "volume": "33",
            "issn": "9",
            "pages": "780--789",
            "other_ids": {}
        },
        "BIBREF145": {
            "ref_id": "b145",
            "title": "Placental 11 beta-hydroxysteroid dehydrogenase: barrier to maternal glucocorticoids",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                }
            ],
            "year": 1997,
            "venue": "Rev Reprod",
            "volume": "2",
            "issn": "3",
            "pages": "129--161",
            "other_ids": {}
        },
        "BIBREF146": {
            "ref_id": "b146",
            "title": "Prophylactic corticosteroids for preterm birth",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Crowley",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Cochrane Database Syst Rev",
            "volume": "",
            "issn": "2",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF147": {
            "ref_id": "b147",
            "title": "Angiotensin II for the Treatment of COVID-19-Related Vasodilatory Shock",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "H"
                    ],
                    "last": "Chow",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "A"
                    ],
                    "last": "Mazzeffi",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "T"
                    ],
                    "last": "Mccurdy",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Anesth Analg",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF148": {
            "ref_id": "b148",
            "title": "Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "H"
                    ],
                    "last": "Kuhn",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Choe",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Farzan",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Cell Mol Life Sci CMLS",
            "volume": "61",
            "issn": "21",
            "pages": "2738--2781",
            "other_ids": {}
        },
        "BIBREF149": {
            "ref_id": "b149",
            "title": "Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Vaduganathan",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Vardeny",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Michel",
                    "suffix": ""
                },
                {
                    "first": "Jjv",
                    "middle": [],
                    "last": "Mcmurray",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "A"
                    ],
                    "last": "Pfeffer",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "D"
                    ],
                    "last": "Solomon",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "N Engl J Med",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF150": {
            "ref_id": "b150",
            "title": "Angiotensin II receptor antagonist treatment during pregnancy",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Alwan",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "E"
                    ],
                    "last": "Polifka",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Friedman",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Birt Defects Res A Clin Mol Teratol",
            "volume": "73",
            "issn": "2",
            "pages": "123--153",
            "other_ids": {}
        },
        "BIBREF151": {
            "ref_id": "b151",
            "title": "Renin Angiotensin System Blocker Fetopathy: A Midwest Pediatric Nephrology Consortium Report",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Nadeem",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Hashmat",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "J"
                    ],
                    "last": "Defreitas",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "D"
                    ],
                    "last": "Westreich",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [
                        "F"
                    ],
                    "last": "Shatat",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "T"
                    ],
                    "last": "Selewski",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "J Pediatr",
            "volume": "167",
            "issn": "4",
            "pages": "881--886",
            "other_ids": {}
        },
        "BIBREF152": {
            "ref_id": "b152",
            "title": "Dysregulation of the placental renin-angiotensin system in human fetal growth restriction",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "J"
                    ],
                    "last": "Delforce",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "R"
                    ],
                    "last": "Lumbers",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "J"
                    ],
                    "last": "Ellery",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Murthi",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "G"
                    ],
                    "last": "Pringle",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Reprod Camb Engl",
            "volume": "158",
            "issn": "3",
            "pages": "237--282",
            "other_ids": {}
        },
        "BIBREF153": {
            "ref_id": "b153",
            "title": "Clinical effect of mifepristone on patients with ovarian cancer in pregnancy",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Shang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Lyu",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Pak J Pharm Sci",
            "volume": "32",
            "issn": "1",
            "pages": "421--427",
            "other_ids": {}
        },
        "BIBREF154": {
            "ref_id": "b154",
            "title": "Gynecologic cancer in pregnancy",
            "authors": [
                {
                    "first": "T-Rk",
                    "middle": [],
                    "last": "Korenaga",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "S"
                    ],
                    "last": "Tewari",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Gynecol Oncol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF155": {
            "ref_id": "b155",
            "title": "Intravitreal Anti-VEGF Injections in Pregnancy: Case Series and Review of Literature",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Polizzi",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [
                        "B"
                    ],
                    "last": "Mahajan",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "J Ocul Pharmacol Ther Off J Assoc Ocul Pharmacol Ther",
            "volume": "31",
            "issn": "10",
            "pages": "605--615",
            "other_ids": {}
        },
        "BIBREF156": {
            "ref_id": "b156",
            "title": "Intravitreal bevacizumab during pregnancy. Retina Phila Pa",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "M"
                    ],
                    "last": "Tarantola",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "C"
                    ],
                    "last": "Folk",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "C"
                    ],
                    "last": "Boldt",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [
                        "B"
                    ],
                    "last": "Mahajan",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "",
            "volume": "30",
            "issn": "",
            "pages": "1405--1416",
            "other_ids": {}
        },
        "BIBREF157": {
            "ref_id": "b157",
            "title": "A short history of thalidomide embryopathy",
            "authors": [
                {
                    "first": "W",
                    "middle": [],
                    "last": "Lenz",
                    "suffix": ""
                }
            ],
            "year": 1988,
            "venue": "Teratology",
            "volume": "38",
            "issn": "3",
            "pages": "203--218",
            "other_ids": {}
        },
        "BIBREF158": {
            "ref_id": "b158",
            "title": "The saga of thalidomide. Neuropathy to embryopathy, with case reports of congenital anomalies",
            "authors": [
                {
                    "first": "G",
                    "middle": [
                        "W"
                    ],
                    "last": "Mellin",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Katzenstein",
                    "suffix": ""
                }
            ],
            "year": 1962,
            "venue": "N Engl J Med",
            "volume": "267",
            "issn": "",
            "pages": "1184--1192",
            "other_ids": {}
        },
        "BIBREF159": {
            "ref_id": "b159",
            "title": "Multiple metastatic gestational trophoblastic disease after a twin pregnancy with complete hydatidiform mole and coexisting fetus, following assisted reproductive technology: Case report and literature review",
            "authors": [
                {
                    "first": "I",
                    "middle": [],
                    "last": "Nobuhara",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Harada",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Haruta",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Higashiura",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Watanabe",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Watanabe",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Taiwan J Obstet Gynecol",
            "volume": "57",
            "issn": "4",
            "pages": "588--93",
            "other_ids": {}
        },
        "BIBREF160": {
            "ref_id": "b160",
            "title": "Good pregnancy outcome after prenatal exposure to bleomycin, etoposide and cisplatin for ovarian immature teratoma: a case report and literature review",
            "authors": [
                {
                    "first": "Karimi",
                    "middle": [],
                    "last": "Zarchi",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Behtash",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                },
                {
                    "first": "Modares",
                    "middle": [],
                    "last": "Gilani",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Arch Gynecol Obstet",
            "volume": "277",
            "issn": "1",
            "pages": "75--83",
            "other_ids": {}
        },
        "BIBREF161": {
            "ref_id": "b161",
            "title": "Methotrexate, bleomycin, and Etoposide in the treatment of gestational trophoblastic neoplasia",
            "authors": [
                {
                    "first": "Hys",
                    "middle": [],
                    "last": "Ngan",
                    "suffix": ""
                },
                {
                    "first": "K-F",
                    "middle": [],
                    "last": "Tam",
                    "suffix": ""
                },
                {
                    "first": "K-W",
                    "middle": [],
                    "last": "Lam",
                    "suffix": ""
                },
                {
                    "first": "Kkl",
                    "middle": [],
                    "last": "Chan",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Obstet Gynecol",
            "volume": "107",
            "issn": "5",
            "pages": "1012--1019",
            "other_ids": {}
        },
        "BIBREF162": {
            "ref_id": "b162",
            "title": "Requirement for etoposide in the treatment of pregnancy related hemophagocytic lymphohistiocytosis: a multicenter retrospective study",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Song",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Hao",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Lu",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Kang",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Orphanet J Rare Dis",
            "volume": "14",
            "issn": "1",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF163": {
            "ref_id": "b163",
            "title": "Liver Enzyme Elevation in Pregnant Women Receiving Antiretroviral Therapy in the ANRS-French Perinatal Cohort",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Sibiude",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Warszawski",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Tubiana",
                    "suffix": ""
                },
                {
                    "first": "Le",
                    "middle": [],
                    "last": "Chenadec",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Meier",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Faye",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "J Acquir Immune Defic Syndr",
            "volume": "81",
            "issn": "1",
            "pages": "83--94",
            "other_ids": {}
        },
        "BIBREF164": {
            "ref_id": "b164",
            "title": "Ethics of studies of drugs in pregnancy",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Matsui",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Paediatr Drugs",
            "volume": "17",
            "issn": "1",
            "pages": "31--36",
            "other_ids": {}
        },
        "BIBREF165": {
            "ref_id": "b165",
            "title": "Increasing the Participation of Pregnant Women in Clinical Trials",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Heyrana",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "M"
                    ],
                    "last": "Byers",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Stratton",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "JAMA",
            "volume": "320",
            "issn": "20",
            "pages": "2077--2085",
            "other_ids": {}
        },
        "BIBREF166": {
            "ref_id": "b166",
            "title": "The ethics of excluding women who become pregnant while participating in clinical trials of anti-epileptic medications",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "G"
                    ],
                    "last": "Beran",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Seizure",
            "volume": "15",
            "issn": "8",
            "pages": "563--70",
            "other_ids": {}
        },
        "BIBREF167": {
            "ref_id": "b167",
            "title": "The moral imperative to approve pregnant women's participation in randomized clinical trials for pregnancy and newborn complications",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "K"
                    ],
                    "last": "Kaye",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Philos Ethics Humanit Med PEHM",
            "volume": "14",
            "issn": "1",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF168": {
            "ref_id": "b168",
            "title": "Models for Placental Transfer Studies of Drugs: Clin Pharmacokinet",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Bourget",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Roulot",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Fernandez",
                    "suffix": ""
                }
            ],
            "year": 1995,
            "venue": "",
            "volume": "28",
            "issn": "",
            "pages": "161--80",
            "other_ids": {}
        },
        "BIBREF169": {
            "ref_id": "b169",
            "title": "Drug Transporters Expressed in the Human Placenta and Models for Studying Maternal-Fetal Drug Transfer",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Dallmann",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [
                        "I"
                    ],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "J"
                    ],
                    "last": "Burckart",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Van Den Anker",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "J Clin Pharmacol",
            "volume": "59",
            "issn": "1",
            "pages": "70--81",
            "other_ids": {}
        },
        "BIBREF170": {
            "ref_id": "b170",
            "title": "Placental transfer of elvitegravir and cobicistat in an ex-vivo human cotyledon double perfusion model",
            "authors": [
                {
                    "first": "V",
                    "middle": [],
                    "last": "Faure-Bardon",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Mandelbrot",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Duro",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Dussaux",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Le",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Peytavin",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "AIDS Lond Engl",
            "volume": "32",
            "issn": "3",
            "pages": "321--326",
            "other_ids": {}
        },
        "BIBREF171": {
            "ref_id": "b171",
            "title": "Contribution and limit of the model of perfused cotyledon to the study of placental transfer of drugs. Example of a protease inhibitor of HIV: nelfinavir",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Gavard",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Beghin",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Forestier",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Cayre",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Peytavin",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Mandelbrot",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Eur J Obstet Gynecol Reprod Biol",
            "volume": "147",
            "issn": "2",
            "pages": "157--60",
            "other_ids": {}
        },
        "BIBREF172": {
            "ref_id": "b172",
            "title": "Prediction of human fetal pharmacokinetics using ex vivo human placenta perfusion studies and physiologically based models",
            "authors": [
                {
                    "first": "De",
                    "middle": [],
                    "last": "Sousa Mendes",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Hirt",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Vinot",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Valade",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Lui",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Pressiat",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Br J Clin Pharmacol",
            "volume": "81",
            "issn": "4",
            "pages": "646--57",
            "other_ids": {}
        },
        "BIBREF173": {
            "ref_id": "b173",
            "title": "Leflunomide use during pregnancy and the risk of adverse pregnancy outcomes",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "B\u00e9rard",
                    "suffix": ""
                },
                {
                    "first": "J-P",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Shui",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Colilla",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Ann Rheum Dis",
            "volume": "77",
            "issn": "4",
            "pages": "500--509",
            "other_ids": {}
        },
        "BIBREF174": {
            "ref_id": "b174",
            "title": "Oseltamivir in pregnancy and birth outcomes",
            "authors": [
                {
                    "first": "V",
                    "middle": [],
                    "last": "Ehrenstein",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "R"
                    ],
                    "last": "Kristensen",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "U"
                    ],
                    "last": "Monz",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Clinch",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Kenwright",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "T"
                    ],
                    "last": "S\u00f8rensen",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "BMC Infect Dis",
            "volume": "18",
            "issn": "1",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF175": {
            "ref_id": "b175",
            "title": "The Ribavirin Pregnancy Registry: An Interim Analysis of Potential Teratogenicity at the Mid-Point of Enrollment",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "M"
                    ],
                    "last": "Sinclair",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "K"
                    ],
                    "last": "Jones",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "K"
                    ],
                    "last": "Miller",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "F"
                    ],
                    "last": "Greene",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "Y"
                    ],
                    "last": "Kwo",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "C"
                    ],
                    "last": "Maddrey",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Drug Saf",
            "volume": "40",
            "issn": "12",
            "pages": "1205--1223",
            "other_ids": {}
        },
        "BIBREF176": {
            "ref_id": "b176",
            "title": "Sildenafil crosses the placenta at therapeutic levels in a dually perfused human cotyledon model",
            "authors": [
                {
                    "first": "F",
                    "middle": [
                        "M"
                    ],
                    "last": "Russo",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Conings",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Allegaert",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Van Mieghem",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Toelen",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Van Calsteren",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Am J Obstet Gynecol",
            "volume": "219",
            "issn": "6",
            "pages": "619--620",
            "other_ids": {}
        },
        "BIBREF177": {
            "ref_id": "b177",
            "title": "Sildenafil in Pregnancy: A Systematic Review of Maternal Tolerance and Obstetric and Perinatal Outcomes",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Dunn",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Greer",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Flenady",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Kumar",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Fetal Diagn Ther",
            "volume": "41",
            "issn": "2",
            "pages": "81--89",
            "other_ids": {}
        },
        "BIBREF178": {
            "ref_id": "b178",
            "title": "Antenatal sildenafil administration to prevent pulmonary hypertension in congenital diaphragmatic hernia (SToP-PH): study protocol for a phase I/IIb placenta transfer and safety study",
            "authors": [
                {
                    "first": "F",
                    "middle": [
                        "M"
                    ],
                    "last": "Russo",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Benachi",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Van Mieghem",
                    "suffix": ""
                },
                {
                    "first": "De",
                    "middle": [],
                    "last": "Hoon",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Van Calsteren",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Annaert",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Trials",
            "volume": "19",
            "issn": "1",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF179": {
            "ref_id": "b179",
            "title": "The effects of sildenafil in maternal and fetal outcomes in pregnancy: A systematic review and meta-analysis",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Ferreira Rd Da",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Negrini",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "M"
                    ],
                    "last": "Bernardo",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Sim\u00f5es",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Piato",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "PloS One",
            "volume": "14",
            "issn": "7",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "144 Chloroquine cardiac toxicities include restrictive cardiomyopathy reported in several cases 145 reports (47-50) and, in case of an overdose, the risk of hypotension and cardiac conduction 146 disorder (prolongation of the QT space and enlargement of the QRS). 147 Concerning pregnant women, pharmacokinetic studies show an increase in clearance of 148 chloroquine and its active metabolite desethylchloroquine (DECQ), especially in the 2nd and 149 3rd trimesters (51,52). Co-administration of azithromycin modestly decreases exposure to 150 (DECQ) without modifying exposure to chloroquine (51). Its use in pregnant women could be 151 responsible for ototoxicity reported in a small study (RR 5.64 [95% CI 1.17 to 27.3])(53). 152 Chloroquine crosses the placenta (85)(84)(54-56) with a mean ratio of cord/maternal con-153 centrations of 1.1 for chloroquine and 1.2 for DECQ . With regards to pregnancy outcomes 154",
            "latex": null,
            "type": "figure"
        },
        "FIGREF1": {
            "text": "drugs commonly used in clinical practice have been proposed (109), alt-248 hough somein vitro studies of antiviral effects on SARS-CoV-2 replication, failed to show an 249 effect of oseltamivir, favipiravir ribavirin or darunavir (21,110). 250",
            "latex": null,
            "type": "figure"
        },
        "FIGREF2": {
            "text": "contraindicated because of its possible teratogenic role in the event of direct or indirect ex-269 posure (pre-conception or in the event of father's treatment). There are some reassuring 270 data (123), but the number of exposures is too small to conclude on safety. 271 Some HIV protease inhibitors are under consideration, (NCT04252274), in addition to lop-272 inavir discussed above. Darunavir with a ritonavir boost has been the most widely used ther-273 apy for HIV in pregnant women in Europe and America for nearly a decade and there are 274 data from prospective cohort studies. There is no increase in the risk of congenital malfor-275",
            "latex": null,
            "type": "figure"
        },
        "FIGREF3": {
            "text": "Clevudine (NCT 04347915) is used in hepatitis B infection in Asian countries. We found no 291 information on its safety profile in pregnancy nor on placental transfer\". 292 293 Other anti-infective drugs 294 \"Ivermectin, usually used to treat parasite infections, is currently under study in COVID-19 295clinical trials (NCT 04390022 and NCT 04381884). Transplacental transfer has been proved in 296",
            "latex": null,
            "type": "figure"
        },
        "FIGREF4": {
            "text": "but 332 was useful in treatment in SARS-CoV infection with a higher discharge rate (control group 333 with usual care represented with 418 patients previously treated in the same center); and 334 especially if given at early phase of disease (n=80) (142). There have been case reports of the 335 use of convalescent plasma transfusion in association with supportive care and antiviral 336 drugs 145,146). Recently, convalescent plasma has been approved by the FDA to treat criti-337 cally ill COVID-19 patients (132-134) and clinical trials are currently being conducted 338 (NCT0432142) ongoing (NCT04321421, NCT 04333355). Past studies have included pregnant 339 women with SARS-CoV-2 (n=1) (143) and Ebola infection (n=8) (141) but the authors recog-340 nized that pregnancy was incompletely recorded in the control group. Concerning trans-341 placental transfer of immunoglobulins; it is well known that transfer of maternal IgG to the 342 fetus plays an important role in preventing neonatal infections. Antibodies are transported 343 across the placenta with mediation of the neonatal Fc receptor (144) and transfer increases 344 with gestational age, mostly in the third trimester. 345 \"Inactivated vaccines are also currently under study (NCT 04352608). Safety in pregnant 346 women have obviously not been assessed. \" 347 348 Immune modulators 349 The leading cause of mortality from COVID-19 is respiratory failure from severe acute respir-350 atory syndrome (SARS). Accumulating evidence suggests that patients with severe COVID-19 351 have a cytokine storm, a hyperinflammatory syndrome characterized by a fulminant and 352 fatal hypercytokinemia and multiorgan failure as well as previously described with SARS-CoV 353 infection (145). Other approaches to anti-inflammatory therapy include cytokine blockers, 354 steroids, and other potent anti-inflammatory agents. 355 Interleukin 6 is a pro-inflammatory cytokine that participates in the cytokine storm which 356 characterizes ARDS in COVID-19. Therefore, anti-IL6 therapies are being considered in 357 COVID-19 pneumonia: tocilizumab (NCT 04317092, NCT 04331795, NCT 04332913) and oth-358 er anti-interleukin molecules such as clazakizumab (NCT04343989), levilimab (NCT 359 04397562), olokizumab (NCT04380519), sarilumab (NCT04315298, NCT04321993, 360 NCT04357808) and siltuximab (NCT04330638, NCT04329650). Tocilizumab is a humanized 361 monoclonal antibody that binds to interleukin-6 receptors and inhibits the signal transmitted 362 by the cytokine. Anti-IL6 therapy is usually used as an immunosuppressant in rheumatoid 363 arthritis and its use requires monitoring of liver function. Tocilizumab crosses the placental 364 barrier and is found in cord blood assays (89% of maternal plasma dosage), plasma assays in 365 newborns (78%) and in milk (11%) (146) with a peak in breast milk reached on the 3rd day 366 after injection (147). There does not seem to be an increased risk of congenital anomalies 367 (148) (149) but the interpretation of the data is difficult because there is often co-exposure 368 with methotrexate. In 2016, at the European Congress of Rheumatology (EULAR), specialists 369 recommended against tocilizumab in pregnancy judging the data insufficient in terms of fetal 370",
            "latex": null,
            "type": "figure"
        },
        "FIGREF5": {
            "text": "421exposed women in familial Mediterranean fever (4 studies and 554 pregnancies with colchi-422 cine exposure)(165). However, in one retrospective study, there was an increased risk of 423 preterm deliveries \u2264 36WG (15% (n=32/214) vs 5.9% (n=51/867) with p<0.01) and a lower 424 median birthweight in singleton full term children (3090g vs 3315g; p<0.01) (166) 425The use of steroids is still controversial for the treatment of SARS-CoV-2 infection. 426Methylprednisone and dexamethasone are being studied in prospective randomized con-427 trolled trials (NCT04273321 and NCT04325061, NCT04329650). Additionally, the glucocorti-428 costeroid ciclesonide has shown in vitro antiviral efficacy against SARS-Cov-2(22). In preg-429 nant women, fluorinated glucocorticosteroids (usually betamethasone two doses of 12 mg) 430 are recommended in case of a high risk of preterm delivery in order to accelerate fetal lung 431 maturation. Their placental transfer is high(167). In contrast, prednisone is inactivated by 432 placental 11\u03b2-hydroxy dehydrogenase(168,169). Betamethasone and dexamethasone in-433 crease blood glucose level but are considered safe for pregnant women. There clinical bene-434 fits have been proved in numerous studies including a metanalysis of 18 trials and over 3700 435 babies (170). Steroids reduce mortality (OR 0.60, IC95% 0.48-0.75) and respiratory distress 436 syndrome (OR 0.53, IC95% 0.44-0.63), and they may also reduce the risk of severe intra-437 ventricular haemorrhage. 438 439 Medications modifying the renin-angiotensin-angiotensin system (RAAS) 440 Drugs that regulate the RAAS have important potential to treat COVID-19. (171). The angio-441 tensin converting enzyme was identified as a SARS-CoV receptor in 2004 (172). Thus, angio-442 tensin converting enzyme (ACE) inhibitors are considered as a therapeutic approach to limit 443 the endocytosis of the viral complex (173) and thereby the number of cells infected with 444",
            "latex": null,
            "type": "figure"
        },
        "FIGREF6": {
            "text": "Other drugs with vascular impact 452Sildenafil, a phosphodiesterase 5 inhibitor, is a vasodilator used to treat erectile dysfunction, 453and also pulmonary arterial hypertension. It is under study in COVID-19 patients (NCT 454 04304313) because pulmonary hypertension is a complication of acute respiratory distress 455 syndrome. In pregnant women, as in non-pregnant patients, the side effects are headache 456",
            "latex": null,
            "type": "figure"
        },
        "FIGREF7": {
            "text": "488 Another therapeutic approach under investigation is the use of fetal-derived cells to reduce 489 inflammation and fibrosis in COVID-19-related lung infection. The study registered as NCT 490 04319731 is a pilot study of nebulized human amniotic fluid. Umbilical cord-derived mesen-491 chymal stromal cells are used in several studies (NCT 04333368, NCT 04315987, 492 NCT04288102). There is no data available on their safety in pregnancy.\"F 493 494 DISCUSSION 495 Among the medications under investigation to treat COVID-19, some already have sufficient 496 safety data to allow their use in pregnant women. These include the HIV protease inhibitors 497 such as lopinavir/ritonavir, interferon and (hydroxy)chloroquine. Also, there are reassuring 498",
            "latex": null,
            "type": "figure"
        },
        "FIGREF8": {
            "text": "Sutton AL, Acosta EP, Larson KB, Kerstner-Wood CD, Tita AT, Biggio JR. Perinatal pharmacokinetics of azithromycin for cesarean prophylaxis. Am J Obstet Gynecol. 2015 Jun;212(6):812.e1-6. 33. Heikkinen T, Laine K, Neuvonen PJ, Ekblad U. The transplacental transfer of the macrolide antibiotics erythromycin, roxithromycin and azithromycin. BJOG Int J Obstet Gynaecol. 2000 Jun;107(6):770-5. 34. B\u00e9rard A, Sheehy O, Zhao J-P, Nordeng H. Use of macrolides during pregnancy and the risk of birth defects: a population-based study. Pharmacoepidemiol Drug Saf. 2015 Dec;24(12):1241-8. 35. Lin KJ, Mitchell AA, Yau W-P, Louik C, Hern\u00e1ndez-D\u00edaz S. Safety of macrolides during pregnancy. Am J Obstet Gynecol. 2013 Mar;208(3):221.e1-8. 36. Cooper WO, Ray WA, Griffin MR. Prenatal prescription of macrolide antibiotics and infantile hypertrophic pyloric stenosis. Obstet Gynecol. 2002 Jul;100(1):101-6. 37. Almaramhy HH, Al-Zalabani AH. The association of prenatal and postnatal macrolide exposure with subsequent development of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis. Ital J Pediatr. 2019 Feb 4;45(1):20.",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "Type of study: Prospective HIV cohort study Population: exposed to LPV/RIT, n=4864 pregnancies Control group: pregnancy as the unit of observation Type of study: prospective cohort study Population: exposed to oseltamivir, n=112 pregnancies Control group: general population\u2022 Major birth defects: (RR 0.84, 95% CI 0.19, 2.80) \u2022 Spontaneous abortion: none reported \u2022 Preterm delivery: (HR 0.65, 95% CI 0.26, 1.63)",
            "latex": null,
            "type": "table"
        },
        "TABREF1": {
            "text": "Type of study: retrospective cohort study Population: HCV-infected women treated with ribavirin in pregnancy, general population from, n=272 pregnant women Control group: Metropolitan Atlanta Congenital Defects Program (MACDP) Dunn(201) Type of study: meta-analysis Population: exposed women, n=165 Control group: unexposed Maternal effects \u2022 Headache: 49/107 (46%), visual trouble: 14/81 (17%) \u2022 Hypotension: 0/39 (0%) \u2022 Caesarean section: 55/66 (83%) Neonatal outcome \u2022 Nursery admission: 35/52 (67.3%) \u2022 Stillbirth: 3/69 (4.3%) and neonatal death: 5/129 (4%) \u2022 Congenital malformations: 0/35 (0%) Type of study: meta-analysis Population: exposed women with pre-eclampsia (n=139) or fetal intra uterine growth restriction (n=275) Control group: unexposed \u2022 birth weight: +223g with high heterogeneity, I=96% \u2022 no difference in gestational age at birth, I=93% \u2022 no significant difference in neonatal death \u2022 no difference in headache, I=69% *in vivo: corresponds to blood samples in mothers and neonates *ex vivo: corresponds to perfused placenta model *F/M: corresponds to comparison of fetal and maternal concentrations, expressed as ratio of concentration or transfer rate (%) * transplacental transfer rate corresponds to ratio of fetal/maternal molecule. It includes parameters such as flow rate or compartment volumes (concentration x flow rate / concentration x flow rate) This formula is often used in open cotyledon circuits 27. Arabi YM, Deeb AM, Al-Hameed F, Mandourah Y, Almekhlafi GA, Sindi AA, et al. Macrolides in critically ill patients with Middle East Respiratory Syndrome. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2019 Apr;81:184-90. 28. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Feb 7; 29. Gautret P, Lagier J-C, Parola P, Hoang VT, Meddeb L, Mailhe M, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label nonrandomized clinical trial. Int J Antimicrob Agents. 2020 Mar 20;105949. 30. Kemp MW, Miura Y, Payne MS, Jobe AH, Kallapur SG, Saito M, et al. Maternal intravenous administration of azithromycin results in significant fetal uptake in a sheep model of second trimester pregnancy. Antimicrob Agents Chemother. 2014 Nov;58(11):6581-91. 31. Acosta EP, Grigsby PL, Larson KB, James AM, Long MC, Duffy LB, et al. Transplacental transfer of Azithromycin and its use for eradicating intra-amniotic ureaplasma infection in a primate model. J Infect Dis. 2014 Mar;209(6):898-904.",
            "latex": null,
            "type": "table"
        },
        "TABREF2": {
            "text": "Fan H, Gilbert R, O'Callaghan F, Li L. Associations between macrolide antibiotics prescribing during pregnancy and adverse child outcomes in the UK: population based cohort study. BMJ. 2020 19;368:m331. 39. Ooi EE, Chew JSW, Loh JP, Chua RCS. In vitro inhibition of human influenza A virus replication by chloroquine. Virol J. 2006 May 29;3:39. 40. Paton NI, Lee L, Xu Y, Ooi EE, Cheung YB, Archuleta S, et al. Chloroquine for influenza prevention: a randomised, double-blind, placebo controlled trial. Lancet Infect Dis. 2011 Sep;11(9):677-83. 41. Savarino A, Di Trani L, Donatelli I, Cauda R, Cassone A. New insights into the antiviral effects of chloroquine. Lancet Infect Dis. 2006 Feb;6(2):67-9. 42. Vincent MJ, Bergeron E, Benjannet S, Erickson BR, Rollin PE, Ksiazek TG, et al. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J. 2005 Aug 22;2:69. 43. Savarino A, Boelaert JR, Cassone A, Majori G, Cauda R. Effects of chloroquine on viral infections: an old drug against today's diseases? Lancet Infect Dis. 2003 Nov;3(11):722-7. 44. Keyaerts E, Vijgen L, Maes P, Neyts J, Van Ranst M. In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine. Biochem Biophys Res Commun. 2004 Oct 8;323(1):264-8. 45. Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020;30(3):269-71. 46. Devaux CA, Rolain J-M, Colson P, Raoult D. New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Int J Antimicrob Agents. 2020 Mar 11;105938. 47. Iglesias Cubero G, Rodriguez Reguero JJ, Rojo Ortega JM. Restrictive cardiomyopathy caused by chloroquine. Br Heart J. 1993 May;69(5):451-2. 48. T\u00f6nnesmann E, Stroehmann I, Kandolf R, Wolburg H, Strach K, Musshoff F, et al. Cardiomyopathy caused by longterm treatment with chloroquine: a rare disease, or a rare diagnosis? J Rheumatol. 2012 May;39(5):1099-103. 49. Yogasundaram H, Hung W, Paterson ID, Sergi C, Oudit GY. Chloroquine-induced cardiomyopathy: a reversible cause of heart failure. ESC Heart Fail. 2018;5(3):372-5. 50. Vereckei A, Fazakas A, Bal\u00f3 T, Fekete B, Moln\u00e1r MJ, Kar\u00e1di I. Chloroquine cardiotoxicity mimicking connective tissue disease heart involvement. Immunopharmacol Immunotoxicol. 2013 Apr;35(2):304-6. 51. Salman S, Baiwog F, Page-Sharp M, Kose K, Karunajeewa HA, Mueller I, et al. Optimal antimalarial dose regimens for chloroquine in pregnancy based on population pharmacokinetic modelling. Int J Antimicrob Agents. 2017 Oct;50(4):542-51. 52. Karunajeewa HA, Salman S, Mueller I, Baiwog F, Gomorrai S, Law I, et al. Pharmacokinetics of chloroquine and monodesethylchloroquine in pregnancy. Antimicrob Agents Chemother. 2010 Mar;54(3):1186-92. 53. Silva VB da, Sousa MA, Kuniyoshi IC, Aur\u00e9lio FS, Sampaio ALL, Oliveira CACP de. Risk of hearing alterations in newborns of mothers treated for malaria. Int Tinnitus J. 2015;19(2):20-5. 54. Augustijns P, Jongsma HW, Verbeke N. Transplacental distribution of chloroquine in sheep. Dev Pharmacol Ther. 1991;17(3-4):191-9.",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}